1
|
Schwob M, Kugler V, Wagner R. Cloning and Overexpressing Membrane Proteins Using Pichia pastoris (Komagataella phaffii). Curr Protoc 2023; 3:e936. [PMID: 37933574 DOI: 10.1002/cpz1.936] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2023]
Abstract
Understanding the structure and function of key proteins located within biological membranes is essential for fundamental knowledge and therapeutic applications. Robust cell systems allowing their actual overexpression are required, among which stands the methylotrophic yeast Pichia pastoris. This system proves highly efficient in producing many eukaryotic membrane proteins of various functions and structures at levels and quality compatible with their subsequent isolation and molecular investigation. This article describes a set of basic guidelines and directions to clone and select recombinant P. pastoris clones overexpressing eukaryotic membrane proteins. Illustrative results obtained for a panel of mammalian membrane proteins are presented, and hints are given on a series of experimental parameters that may substantially improve the amount and/or the functionality of the expressed proteins. © 2023 The Authors. Current Protocols published by Wiley Periodicals LLC. Basic Protocol 1: Designing and cloning a P. pastoris expression vector Basic Protocol 2: Integrative transformation of P. pastoris and selection of recombinant clones Basic Protocol 3: Culturing transformed P. pastoris for membrane protein expression Basic Protocol 4: Yeast cell lysis and membrane preparation Basic Protocol 5: Immunodetection of expressed membrane proteins: western blot Alternate Protocol 1: Immunodetection of expressed membrane proteins: dot blot Alternate Protocol 2: Immunodetection of expressed membrane proteins: yeastern blot Basic Protocol 6: Activity assay: ligand-binding analysis of an expressed GPCR.
Collapse
Affiliation(s)
- Magali Schwob
- IMPReSs Facility, Biotechnology and Cell Signaling, University of Strasbourg-CNRS, Illkirch, France
- Department of Structural Biology, NovAliX, Strasbourg, France
| | - Valérie Kugler
- IMPReSs Facility, Biotechnology and Cell Signaling, University of Strasbourg-CNRS, Illkirch, France
| | - Renaud Wagner
- IMPReSs Facility, Biotechnology and Cell Signaling, University of Strasbourg-CNRS, Illkirch, France
| |
Collapse
|
2
|
Deloche A, Vidal FX, Jammas L, Wagner R, Dugas V, Demesmay C. Extending the Affinity Range of Weak Affinity Chromatography for the Identification of Weak Ligands Targeting Membrane Proteins. Molecules 2023; 28:7113. [PMID: 37894592 PMCID: PMC10608817 DOI: 10.3390/molecules28207113] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/06/2023] [Revised: 10/05/2023] [Accepted: 10/11/2023] [Indexed: 10/29/2023] Open
Abstract
The identification of weak-affinity ligands targeting membrane proteins is of great interest in Fragment-Based Drug Design (FBDD). Recently, miniaturized weak affinity chromatography (WAC) has been proposed as a valuable tool to study interactions between small ligands and wild-type membrane proteins embedded in so-called nanodisc biomimetic membranes immobilized on GMA-co-EDMA monoliths in situ-synthesized in capillary columns (less than one microliter in volume). In this proof-of-concept study, the achievable affinity range was limited to medium affinity (low micromolar range). The present work investigates different strategies to extend the affinity range towards low affinities, either by increasing the density of membrane proteins on the chromatographic support or by reducing non-specific interactions with the monolith. The combination of the use of a new and more hydrophilic monolithic support (poly(DHPMA-co-MBA)) and a multilayer nanodisc grafting process (up to three layers) allows a significant increase in the membrane protein density by a more than three-fold factor (up to 5.4 pmol cm-1). Such an increase in protein density associated with reduced non-specific interactions makes it possible to extend the range of detectable affinity, as demonstrated by the identification and characterization of affinities of very low-affinity ligands (Kd values of several hundred micromolar) for the adenosine receptor AA2AR used as a model protein, which was not possible before. The affinity was confirmed by competition experiments.
Collapse
Affiliation(s)
- Adrien Deloche
- Institut des Sciences Analytique, Universite Claude Bernard Lyon 1, ISA UMR 5280, CNRS, 5 Rue de la Doua, 69100 Villeurbanne, France; (A.D.); (F.-X.V.); (V.D.)
| | - François-Xavier Vidal
- Institut des Sciences Analytique, Universite Claude Bernard Lyon 1, ISA UMR 5280, CNRS, 5 Rue de la Doua, 69100 Villeurbanne, France; (A.D.); (F.-X.V.); (V.D.)
| | - Lucile Jammas
- Plateforme IMPReSs, CNRS UMR7242, Biotechnologie et Signalisation Cellulaire, Ecole Supérieure de Biotechnologie de Strasbourg, 67400 Illkirch, France (R.W.)
| | - Renaud Wagner
- Plateforme IMPReSs, CNRS UMR7242, Biotechnologie et Signalisation Cellulaire, Ecole Supérieure de Biotechnologie de Strasbourg, 67400 Illkirch, France (R.W.)
| | - Vincent Dugas
- Institut des Sciences Analytique, Universite Claude Bernard Lyon 1, ISA UMR 5280, CNRS, 5 Rue de la Doua, 69100 Villeurbanne, France; (A.D.); (F.-X.V.); (V.D.)
| | - Claire Demesmay
- Institut des Sciences Analytique, Universite Claude Bernard Lyon 1, ISA UMR 5280, CNRS, 5 Rue de la Doua, 69100 Villeurbanne, France; (A.D.); (F.-X.V.); (V.D.)
| |
Collapse
|
3
|
Zeder-Lutz G, Bornert O, Fellmann-Clauss R, Knittel-Obrecht A, Tranchant T, Bouteben S, Kaeffer J, Quillet R, Villa P, Wagner R, Lecat S, Simonin F. Characterization of anti-GASP motif antibodies that inhibit the interaction between GPRASP1 and G protein-coupled receptors. Anal Biochem 2023; 665:115062. [PMID: 36731712 DOI: 10.1016/j.ab.2023.115062] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/13/2022] [Revised: 01/17/2023] [Accepted: 01/24/2023] [Indexed: 02/03/2023]
Abstract
G protein-coupled receptor associated sorting protein 1 (GPRASP1) belongs to a family of 10 proteins that display sequence homologies in their C-terminal region. Several members including GPRASP1 also display a short repeated sequence called the GASP motif that is critically involved in protein-protein interactions with G protein-coupled receptors (GPCRs). Here, we characterized anti-GASP motif antibodies and investigated their potential inhibitory functions. We first showed that our in-house anti-GPRASP1 rabbit polyclonal serum contains anti-GASP motif antibodies and purified them by affinity chromatography. We further showed that these antibodies can detect GPRASP1 and GPRASP2 in Western blot, immunoprecipitation and immunofluorescence experiments while a mutant of GPRASP2, in which the most conserved hydrophobic core of the GASP motifs is mutated, was no more detected. Further characterization of anti-GASP motif antibodies by ELISA and Surface Plasmon Resonance assays suggests that GASP motifs function as multivalent epitopes. Finally, we set-up an Amplified Luminescent Proximity Homogeneous AlphaScreen® assay to detect the interaction between purified ADRB2 receptor and the central domain of GPRASP1 and showed that anti-GASP motif antibodies efficiently inhibit this interaction. Altogether, our results suggest that anti-GASP motif antibodies could represent a valuable tool to neutralize the interaction of GPRASP1 and GPRASP2 with different GPCRs.
Collapse
Affiliation(s)
- Gabrielle Zeder-Lutz
- Biotechnology and Cell Signaling, UMR7242 CNRS, University of Strasbourg, Illkirch-Graffenstaden, France
| | - Olivier Bornert
- Biotechnology and Cell Signaling, UMR7242 CNRS, University of Strasbourg, Illkirch-Graffenstaden, France
| | - Rosine Fellmann-Clauss
- Biotechnology and Cell Signaling, UMR7242 CNRS, University of Strasbourg, Illkirch-Graffenstaden, France
| | - Adeline Knittel-Obrecht
- Plateforme de Chimie Biologique integrative de Strasbourg, UAR3286, CNRS, University of Strasbourg, Illkirch-Graffenstaden, France
| | - Thibaud Tranchant
- Biotechnology and Cell Signaling, UMR7242 CNRS, University of Strasbourg, Illkirch-Graffenstaden, France
| | - Sarah Bouteben
- Biotechnology and Cell Signaling, UMR7242 CNRS, University of Strasbourg, Illkirch-Graffenstaden, France; Biotechnology and Cell Signaling, IMPReSs facility for Integral Membrane Proteins Research and Services, UMR7242 CNRS, University of Strasbourg, Illkirch-Graffenstaden, France
| | - Juliette Kaeffer
- Biotechnology and Cell Signaling, UMR7242 CNRS, University of Strasbourg, Illkirch-Graffenstaden, France
| | - Raphaëlle Quillet
- Biotechnology and Cell Signaling, UMR7242 CNRS, University of Strasbourg, Illkirch-Graffenstaden, France
| | - Pascal Villa
- Plateforme de Chimie Biologique integrative de Strasbourg, UAR3286, CNRS, University of Strasbourg, Illkirch-Graffenstaden, France
| | - Renaud Wagner
- Biotechnology and Cell Signaling, UMR7242 CNRS, University of Strasbourg, Illkirch-Graffenstaden, France; Biotechnology and Cell Signaling, IMPReSs facility for Integral Membrane Proteins Research and Services, UMR7242 CNRS, University of Strasbourg, Illkirch-Graffenstaden, France
| | - Sandra Lecat
- Biotechnology and Cell Signaling, UMR7242 CNRS, University of Strasbourg, Illkirch-Graffenstaden, France
| | - Frédéric Simonin
- Biotechnology and Cell Signaling, UMR7242 CNRS, University of Strasbourg, Illkirch-Graffenstaden, France.
| |
Collapse
|
4
|
Ritt L, Orso C, Silveira A, Frazzon J, de Vargas D, Wagner R, de Oliveira F, Nörnberg J, Fischer V. Oregano extract fed to pre-weaned dairy calves. Part 1: effects on intake, digestibility, body weight, and rumen and intestinal bacteria microbiota. Livest Sci 2023. [DOI: 10.1016/j.livsci.2023.105165] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/26/2023]
|
5
|
Zanini L, Dian E, DiJulio D, Folsom B, Klinkby E, Kokai Z, Marquez Damian J, Rataj B, Rizzi N, Santoro V, Strothmann M, Takibayev A, Wagner R, Zimmer O. Very cold and ultra cold neutron sources for ESS. JNR 2022. [DOI: 10.3233/jnr-220040] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
The goal of the “Workshop on Very Cold and Ultra Cold Neutron Sources for ESS” was to discuss scientific cases, ideas and possibilities for the implementation of sources of Very Cold and Ultra Cold neutrons at the European Spallation Source. The ESS facility, presently under construction, offers several possibilities for in-pile UCN or VCN sources, in primis thanks to the available space below the spallation target where additional neutron sources can be placed to complement those above the target. Neutron beams can be extracted over a wide angular range with a grid of forty-two beamports with 6° average angular separation, allowing future instruments to be installed which may view either the upper or lower moderator systems. Of greatest interest for fundamental physics is the so-called Large Beamport foreseen for the NNBAR experiment. This beamport is also particularly well suited to feed a UCN source, for which several ideas were presented that employ either superfluid helium or solid deuterium as established neutron converter materials. Concepts for VCN sources make use of novel materials for VCN production and/or advanced reflectors to increase yields in the coldest part of the neutron spectrum from a cryogenic neutron source. In this paper we discuss these ideas and the possible locations of UCN and VCN sources at ESS.
Collapse
Affiliation(s)
- L. Zanini
- European Spallation Source ERIC, Partikelgatan 2, 22484 Lund, Sweden
| | - E. Dian
- Mirrotron Ltd., 29-33 Konkoly Thege Miklós út, 1121 Budapest, Hungary
- Centre for Energy Research, 29-33 Konkoly Thege Miklós út, 1121 Budapest, Hungary
| | - D.D. DiJulio
- European Spallation Source ERIC, Partikelgatan 2, 22484 Lund, Sweden
| | - B. Folsom
- University of Milano-Bicocca, Milano, Italy
| | - E.B. Klinkby
- DTU Physics, Technical University of Denmark, Frederiksborgvej 399, DK-4000 Roskilde, Denmark
| | - Z. Kokai
- European Spallation Source ERIC, Partikelgatan 2, 22484 Lund, Sweden
| | | | - B. Rataj
- European Spallation Source ERIC, Partikelgatan 2, 22484 Lund, Sweden
| | - N. Rizzi
- DTU Physics, Technical University of Denmark, Frederiksborgvej 399, DK-4000 Roskilde, Denmark
| | - V. Santoro
- European Spallation Source ERIC, Partikelgatan 2, 22484 Lund, Sweden
| | - M. Strothmann
- Forschungszentrum Jülich GmbH, Central Institute for Engineering, Electronics and Analytics (ZEA-1), Wilhelm-Johnen-Str., 52428 Jülich, Germany
| | - A. Takibayev
- European Spallation Source ERIC, Partikelgatan 2, 22484 Lund, Sweden
| | - R. Wagner
- Institut Laue-Langevin, 71 Avenue des Martyrs, 38042 Grenoble, France
| | - O. Zimmer
- Institut Laue-Langevin, 71 Avenue des Martyrs, 38042 Grenoble, France
| |
Collapse
|
6
|
Ferro EG, Abrahams-Gessel S, Kapaon D, Houle B, Wagner R, Gomez-Olive X, Wade AN, Tollman S, Gaziano TA. Significant improvement in blood pressure control among older adults with hypertension in rural South Africa: findings from a prospective 5,000-patient cohort, 2014–2019. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.2542] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
Abstract
Background
Sub-Saharan Africa is undergoing an epidemiologic transition dominated by a widespread epidemic of hypertension (HTN). Since 2014, we began studying a cohort of 5,059 individuals in rural South Africa, to describe the evolution of HTN among older adults, and understand the impact of targeted interventions by local health systems.
Purpose
Characterize the updated prevalence and incidence of HTN in a prospective cohort between baseline (2014) and follow-up (2019), and describe changes in blood pressure (BP) treatment.
Methods
HTN was defined as systolic blood pressure (SBP) ≥140 mm Hg, diastolic blood pressure (DBP) ≥90 mm Hg, or self-reported medication use. Prevalence and incidence rates were calculated using inverse-probability weights to account for mortality and attrition. Poisson regression was used to identify predictors of disease incidence. We calculated the percentage of individuals with controlled versus uncontrolled HTN (with 140/90 mm Hg as cutoff), self-reported medication use, and compared these values between 2014 and 2019.
Results
Compared to 2014 (n=5,059), study participants in 2019 (n=4,176) were expectedly older (mean age 61.7±13.1 vs 66.0±13.0 years) but had similar sex distribution (53.6% vs 53.5% females) and weighted rates of obesity (mean BMI 27.5±10.0 vs 27.0±6.5), with higher rates of smoking (9.1% vs 11.8%) and diabetes (11.1% vs 13.7%). The HTN prevalence did not increase over time (58.4% vs 59.8%), and there was a significant reduction in mean SBP (138.0 vs 128.5 mm Hg, p<0.001) and DBP (82.1 vs 79.6 mm Hg, p<0.001). In the subgroup of hypertensive individuals with measured BP and self-reported medication use in both 2014 and 2019 (n=796), the percentage who had controlled HTN on medications increased from 44.5% to 62.3% while the percentage who had uncontrolled HTN on medications or uncontrolled HTN not on medications decreased (48.5% to 32.2% and 7.2% to 3%, respectively) from 2014 to 2019 (Figure 1). The HTN incidence was 6.2 per 100 person-years, which was lower than prior reports from this area (8.4 per 100 person-years in 2010–2015); in multivariable models, age was the only significant predictor of incident HTN. In the subgroup of individuals who were healthy at baseline with measured BP and self-reported medication use in 2014 and 2019 (n=2,257), very few developed HTN by 2019 (15.2%); of those, the majority already had controlled HTN and was on medications by 2019 (Figure 2).
Conclusions
The prevalence of HTN did not increase in this aging cohort; in fact there was a clinically and statistically significant decline in mean BP and a substantial increase in the proportion of hypertensive patients with controlled HTN taking medications between 2014 and 2019. The prevalence of obesity, smoking and other risk factors did not decrease over time, suggesting that the mean BP decrease in this cohort is likely due to increased access and adherence to medications, promoted by local health systems.
Funding Acknowledgement
Type of funding sources: Public grant(s) – National budget only. Main funding source(s): National Institute on Aging (P01 AG041710), and Department of Science and Innovation, the University of the Witwatersrand, South Africa.
Collapse
Affiliation(s)
- E G Ferro
- Brigham and Women'S Hospital, Harvard Medical School, Cardiology , Boston , United States of America
| | - S Abrahams-Gessel
- Harvard T. H. Chan School of Public Health, Center for Health Decision Science , Boston , United States of America
| | - D Kapaon
- Harvard T. H. Chan School of Public Health, Center for Health Decision Science , Boston , United States of America
| | - B Houle
- Australian National University, School of Demography , Canberra , Australia
| | - R Wagner
- University of the Witwatersrand , Johannesburg , South Africa
| | - X Gomez-Olive
- University of the Witwatersrand , Johannesburg , South Africa
| | - A N Wade
- University of the Witwatersrand , Johannesburg , South Africa
| | - S Tollman
- University of the Witwatersrand , Johannesburg , South Africa
| | - T A Gaziano
- Brigham and Women'S Hospital, Harvard Medical School, Cardiology , Boston , United States of America
| |
Collapse
|
7
|
Fernandes CAH, Zuniga D, Fagnen C, Kugler V, Scala R, Péhau-Arnaudet G, Wagner R, Perahia D, Bendahhou S, Vénien-Bryan C. Cryo-electron microscopy unveils unique structural features of the human Kir2.1 channel. Sci Adv 2022; 8:eabq8489. [PMID: 36149965 PMCID: PMC9506730 DOI: 10.1126/sciadv.abq8489] [Citation(s) in RCA: 8] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 05/10/2022] [Accepted: 08/04/2022] [Indexed: 06/16/2023]
Abstract
We present the first structure of the human Kir2.1 channel containing both transmembrane domain (TMD) and cytoplasmic domain (CTD). Kir2.1 channels are strongly inward-rectifying potassium channels that play a key role in maintaining resting membrane potential. Their gating is modulated by phosphatidylinositol 4,5-bisphosphate (PIP2). Genetically inherited defects in Kir2.1 channels are responsible for several rare human diseases, including Andersen's syndrome. The structural analysis (cryo-electron microscopy), surface plasmon resonance, and electrophysiological experiments revealed a well-connected network of interactions between the PIP2-binding site and the G-loop through residues R312 and H221. In addition, molecular dynamics simulations and normal mode analysis showed the intrinsic tendency of the CTD to tether to the TMD and a movement of the secondary anionic binding site to the membrane even without PIP2. Our results revealed structural features unique to human Kir2.1 and provided insights into the connection between G-loop and gating and the pathological mechanisms associated with this channel.
Collapse
Affiliation(s)
- Carlos A. H. Fernandes
- UMR 7590, CNRS, Muséum National d’Histoire Naturelle, IRD, Institut de Minéralogie, Physique des Matériaux et de Cosmochimie, IMPMC, Sorbonne Université, 75005 Paris, France
| | - Dania Zuniga
- UMR 7590, CNRS, Muséum National d’Histoire Naturelle, IRD, Institut de Minéralogie, Physique des Matériaux et de Cosmochimie, IMPMC, Sorbonne Université, 75005 Paris, France
| | - Charline Fagnen
- UMR 7590, CNRS, Muséum National d’Histoire Naturelle, IRD, Institut de Minéralogie, Physique des Matériaux et de Cosmochimie, IMPMC, Sorbonne Université, 75005 Paris, France
| | - Valérie Kugler
- IMPReSs Facility, Biotechnology and Cell Signaling UMR 7242, CNRS–University of Strasbourg, Illkirch, Cedex, France
| | - Rosa Scala
- CNRS UMR7370, LP2M, Labex ICST, Faculté de Médecine, Université Côte d’Azur, Nice, France
| | - Gérard Péhau-Arnaudet
- Ultrastructural BioImaging Core Facility/UMR 3528, Institut Pasteur, 75724 Paris Cedex 15, France
| | - Renaud Wagner
- IMPReSs Facility, Biotechnology and Cell Signaling UMR 7242, CNRS–University of Strasbourg, Illkirch, Cedex, France
| | - David Perahia
- Laboratoire de Biologie et Pharmacologie Appliquée, Ecole Normale Supérieure Paris-Saclay, 4 Ave. des Sciences, 91190 Gif-sur-Yvette, France
| | - Saïd Bendahhou
- CNRS UMR7370, LP2M, Labex ICST, Faculté de Médecine, Université Côte d’Azur, Nice, France
| | - Catherine Vénien-Bryan
- UMR 7590, CNRS, Muséum National d’Histoire Naturelle, IRD, Institut de Minéralogie, Physique des Matériaux et de Cosmochimie, IMPMC, Sorbonne Université, 75005 Paris, France
| |
Collapse
|
8
|
Hansen J, Mrazik M, Wagner R, Ree-Fedun Q, David C, Arends P, Varkovestski M, Naidu D. A-19 Distress Predicts Poorer Cognitive Performance At Post-Injury In Concussed Athletes. Arch Clin Neuropsychol 2022. [DOI: 10.1093/arclin/acac32.19] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Purpose: This study evaluated the consistency between athletes’ self-reported cognitive symptoms and cognitive test performance. Methods: The sample included 784 Canadian Football League athletes who underwent standardized cognitive testing with cognitive testing (ImPACT) and the Brief Symptom Inventory (BSI-18) at baseline. Over 2 consecutive seasons, 46 players were diagnosed with concussions following assessment with team physicians within 48 hours; 10 were eliminated due to missing data. Five cognitive symptoms (feeling slowed down, feeling in a fog, not feeling right, difficulties concentration, difficulties with memory) were used to create a composite score (Cog). The Cog index, the depression, anxiety, total index scores from the BSI, and the 5 ImPACT cognitive domains were correlated at baseline and post-injury. History of learning disabilities, ADHD, psychiatric diagnosis, and history of concussion were co-variates. Results: There were no significant correlations between Cog, depression, anxiety or total BSI scores and the ImPACT cognitive domains at baseline. At post injury there were no significant correlations between Cog or ImPACT index scores. In contrast, significant negative correlations were found between BSI Anxiety and verbal memory (r = 0.67, p < 0.01), visual memory (r = 0.68, p < 0.01), and visual-motor processing speed (r = 0.48, p < 0.05). In addition, there were significant negative correlations between the BSI total score and visual memory (r = 0.51, p < 0.05) and reaction time (r = 0.55, p < 0.05). Conclusions: Self-reported cognitive difficulties do not correlate with poorer cognitive outcomes in our sample of professional football players. However, distress at post-injury was significantly correlated to performance, suggesting psychological variables may play a role in cognitive functioning.
Collapse
|
9
|
Ree-Fedun Q, Naidu D, Mrazik M, David C, Hansen J, Wagner R, Arends T. A-37 Ocular Motor Impairments in Concussion Professional Football Players. Arch Clin Neuropsychol 2022. [DOI: 10.1093/arclin/acac32.37] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Purpose: The purpose of this study was to examine baseline and post-concussion injury characteristics of ocular eye movements using the Sync Think visual eye tracking apparatus in professional football players in the Canadian Football League (CFL). Methods: The visual tracking testing protocol uses an integrated stimulus presentation-eye tracking apparatus (EyeLink CL; SR Research, Ontario, Canada) with which eye movements were recorded at 500 Hz using infrared video-oculography. The standard deviation of radial errors (SDRE) and tangential errors (SDTE) were used to determine poor visual tracking. Participants were (n = 748) rostered players in the Canadian Football League. All participants completed assessments at baseline. Sixteen players completed post-concussion assessments and 98 players completed post-exertional assessments during the 2021 season to evaluate the impact of physical exertion on ocular movement metrics. Results: Participants with diagnosed concussions (n = 16+) demonstrated significantly poorer performance on measures of both gaze stability and smooth pursuit (p < 0.001). The poorer results were correlated with significantly higher subjective ratings of dizziness (p < 0.01) and fogginess (p < 0.001). In contrast, healthy participants who completed the same ocular motor assessments demonstrated no significant differences compared to baseline test performance. Conclusions: Findings suggest that subtle differences in oculomotor functioning arise from sport concussion in professional football players. Further research with larger sample sizes and correlation with other cognitive and physical outcomes is warranted.
Collapse
|
10
|
David CV, Varkovetski M, Wagner R, Ree-Fedun Q, Hansen J, Arends T, Naidu D, Mrazik M. A-12 Mental Health Outcomes for CFL Athletes with ADHD. Arch Clin Neuropsychol 2022. [DOI: 10.1093/arclin/acac32.12] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Purpose: Current research suggests that athletes with Attention Deficit Hyperactivity Disorder (ADHD) are at risk for poorer outcomes arising from sport related concussions (SRC). There is limited research related evaluating mental health outcomes in athletes diagnosed with ADHD. The purpose of the study is to evaluate mental health outcomes among Canadian Football League (CFL) athletes with (ADHD) and to measure outcomes based upon a history of concussion. Methods: Professional football players from the CFL (n = 784) were administered a baseline mental health measure, the Health-Related Quality of Life (HRQL), as a component of pre-season evaluations as part of a larger cohort study (Active Rehabilitation). Diagnosis of ADHD was the independent variable and HRQL index scores measuring physical functioning, depression, cognitive functioning, were dependent variables. A second analysis compared ADHD athletes with no history of concussion to those with a history of concussion on the HRQL indexes. Results: Participants diagnosed with ADHD (n = 80) had statistically significant differences on the Physical Functioning (t(782) = −3.359, p < 0.001), Depression ((t(782) = −2.820, p = 0.002) and Cognitive (t(782) = −3.570, p < 0.001) domains of the HRQL, compared to athletes without ADHD. Among the athletes who are diagnosed with ADHD, no mental health differences were found between those who have at least one concussion and those who do not. Conclusions: This study did not find a significant effect of concussion on mental health outcomes in participants with ADHD. However, athletes with ADHD present with higher mental health symptoms which may merit closer monitoring.
Collapse
|
11
|
Kromp F, Balaban B, Cottin V, Saiz IC, Fancsovits P, Fawzy M, Findikli N, Kovacic B, Ljiljak D, Rodero IM, Parmegiani L, Shebl O, Wagner R, Xie M, Ebner T. O-285 Artificial intelligence algorithms reach expert-level accuracy in automated grading of blastocyst morphology assessment based on static embryo images and Gardner criteria. Hum Reprod 2022. [DOI: 10.1093/humrep/deac106.078] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Study question
Can artificial intelligence (AI) algorithms reach expert-level accuracy in blastocyst morphology assessment according to Gardner criteria?
Summary answer
The prediction accuracy of the best performing AI algorithm (Deit), outperformed human-level mean accuracies compared to an embryologist majority vote for all Gardner morphological criteria.
What is known already
Routinely, morphological grading of blastocysts is performed visually according to Gardner criteria, which suggest expansion (EXP), quality of inner cell mass (ICM), and trophectoderm (TE) as key parameters to predict treatment outcome. Consequently, blastocyst scoring is prone to inter-and intra-observer variability, which may lead to inconsistencies in selecting blastocysts for transfer. AI-based algorithms may help to improve treatment outcome predictability, as it has been suggested recently. In those studies, parameters such as blastocyst quality or stage were annotated by experts from static or time-lapse-derived blastocyst images, to train AI algorithms, e.g. XCeption or YOLO, and compare them to human annotators.
Study design, size, duration
This retrospective study involves 2,270 images from 837 patients collected over a period of four years in a university IVF clinic.
Participants/materials, setting, methods
All images were annotated by one senior embryologist and divided into a training and a balanced test set. Subsequently, eight embryologists labeled 300 test set images such that every single image was seen by at least four embryologists. Annotators diverging from the ensemble vote for more than one standard deviation were excluded (n = 2) to set the ground truth labels. Finally, three AI architectures (XCeption, Swin, Deit) were trained and evaluated on that particular ground truth.
Main results and the role of chance
Out of nine annotators, labelling accuracy of two embryologists diverged from the consensus vote for more than one standard deviation for at least one of the three Gardner criteria. The consensus vote was built from the remaining seven annotators (mean accuracy EXP 0.81, ICM 0.70, TE 0.67). The Swin architecture outperformed the mean expert accuracy for all three criteria (EXP 0.82, ICM 0.76, TE 0.68), while the Deit and the XCeption architecture outperformed the mean expert accuracy in ICM accuracy (Deit 0.72, XCeption 0.73), and performed equal or worse in EXP and TE accuracy (Deit EXP 0.77, ICM 0.73; XCeption EXP 0.77, TE 0.66). When compared to a recent study conducted on time-lapse imaging data using AI algorithms, all our models outperform the ICM accuracy and achieve comparable TE accuracy. To minimize the role of chance in calculating the models' prediction accuracies, the SWA-Gaussian (SWAG) algorithm was used. SWAG is a method to reflect and calibrate uncertainty representation in Bayesian deep learning. It is based on modelling a Gaussian distribution for each networks' weight and applying it as a posterior over all neural network weights to perform Bayesian model averaging.
Limitations, reasons for caution
To reflect a real IVF lab scenario, embryologists of different origins and levels of experience were involved and no scoring training was offered to the participants. These facts could have potentially negatively affected the degree of consensus, although we excluded two annotators diverging from the mean labeling accuracy.
Wider implications of the findings
In the past, AI algorithms proved to reliably differentiate between good and bad prognosis blastocysts but not necessarily between blastocysts of similar quality. Further AI-supported differentiation on the basis of expansion and cell lineages will facilitate the ranking of blastocysts and would bring automated scoring closer to clinical application.
Trial registration number
Not applicable.
Collapse
Affiliation(s)
- F Kromp
- Software Competence Center Hagenberg, Data science , Hagenberg, Austria
| | - B Balaban
- American Hospital of Istanbul, In vitro fertilization lab , Istanbul, Turkey
| | - V Cottin
- Bethesda Spital Basel, Assisted Reproduction Technology Unit , Basel, Switzerland
| | - I. Cuevas Saiz
- Hospital General Universitario de Valencia, In vitro fertilization lab , Valencia, Spain
| | - P Fancsovits
- Semmelweis University School of Medicine, Division of Assisted Reproduction , Budapest, Hungary
| | - M Fawzy
- IbnSina and Banon IVF Centers, In vitro fertilization lab , Sohag, Egypt
| | - N Findikli
- Bahceci Fulya IVF Centre Istanbul, In vitro fertilization lab , Istanbul, Turkey
| | - B Kovacic
- University Medical Centre Maribor, Department of Reproductive Medicine and Gynecological Endocrinology , Maribor, Slovenia
| | - D Ljiljak
- Sestre Milosrdnice University Hospital Center, Department of Gynecology and Obstetrics , Zagreb, Croatia
| | - I. Martínez Rodero
- Universitat Autònoma de Barcelona, Laboratori de Fecundació In Vitro , Barcelona, Spain
| | - L Parmegiani
- GynePro Medical Centers , Embryology lab , Bologna, Italy
| | - O Shebl
- Kepler University Linz, Gynecology- Obstetrics and Gynecological Endocrinology , Linz, Austria
| | - R Wagner
- Software Competence Center Hagenberg, Services and solutions , Hagenberg, Austria
| | - M Xie
- University Hospital Zurich, Department of Reproductive Endocrinology , Zurich, Switzerland
| | - T Ebner
- Kepler University Linz, Gynecology- Obstetrics and Gynecological Endocrinology , Linz, Austria
| |
Collapse
|
12
|
Vollroth M, Misfeld M, Meier S, Krögh G, Schumacher K, Wagner R, Dähnert I, Borger MA, Kostelka M. Die Ross-Operation bei Kindern: Aspekte der chirurgischen Technik. Z Herz- Thorax- Gefäßchir 2022. [DOI: 10.1007/s00398-022-00495-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
13
|
Kastirke G, Ota F, Rezvan DV, Schöffler MS, Weller M, Rist J, Boll R, Anders N, Baumann TM, Eckart S, Erk B, De Fanis A, Fehre K, Gatton A, Grundmann S, Grychtol P, Hartung A, Hofmann M, Ilchen M, Janke C, Kircher M, Kunitski M, Li X, Mazza T, Melzer N, Montano J, Music V, Nalin G, Ovcharenko Y, Pier A, Rennhack N, Rivas DE, Dörner R, Rolles D, Rudenko A, Schmidt P, Siebert J, Strenger N, Trabert D, Vela-Perez I, Wagner R, Weber T, Williams JB, Ziolkowski P, Schmidt LPH, Czasch A, Tamura Y, Hara N, Yamazaki K, Hatada K, Trinter F, Meyer M, Ueda K, Demekhin PV, Jahnke T. Investigating charge-up and fragmentation dynamics of oxygen molecules after interaction with strong X-ray free-electron laser pulses. Phys Chem Chem Phys 2022; 24:27121-27127. [DOI: 10.1039/d2cp02408j] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
The X-ray-induced charge-up and fragmentation process of a small molecule is examined in great detail by measuring the molecular-frame photoelectron interference pattern in conjunction with other observables in coincidence.
Collapse
Affiliation(s)
- G. Kastirke
- Institut für Kernphysik, Goethe-Universität, Max-von-Laue-Straße 1, 60438 Frankfurt am Main, Germany
| | - F. Ota
- Department of Physics, University of Toyama, Gofuku 3190, Toyama 930-8555, Japan
| | - D. V. Rezvan
- Institut für Physik und CINSaT, Universität Kassel, Heinrich-Plett-Straße 40, 34132 Kassel, Germany
| | - M. S. Schöffler
- Institut für Kernphysik, Goethe-Universität, Max-von-Laue-Straße 1, 60438 Frankfurt am Main, Germany
| | - M. Weller
- Institut für Kernphysik, Goethe-Universität, Max-von-Laue-Straße 1, 60438 Frankfurt am Main, Germany
| | - J. Rist
- Institut für Kernphysik, Goethe-Universität, Max-von-Laue-Straße 1, 60438 Frankfurt am Main, Germany
| | - R. Boll
- European XFEL, Holzkoppel 4, 22869 Schenefeld, Germany
| | - N. Anders
- Institut für Kernphysik, Goethe-Universität, Max-von-Laue-Straße 1, 60438 Frankfurt am Main, Germany
| | - T. M. Baumann
- European XFEL, Holzkoppel 4, 22869 Schenefeld, Germany
| | - S. Eckart
- Institut für Kernphysik, Goethe-Universität, Max-von-Laue-Straße 1, 60438 Frankfurt am Main, Germany
| | - B. Erk
- Deutsches Elektronen-Synchrotron DESY, Notkestraße 85, 22607 Hamburg, Germany
| | - A. De Fanis
- European XFEL, Holzkoppel 4, 22869 Schenefeld, Germany
| | - K. Fehre
- Institut für Kernphysik, Goethe-Universität, Max-von-Laue-Straße 1, 60438 Frankfurt am Main, Germany
| | - A. Gatton
- SLAC National Accelerator Laboratory, Menlo Park, California 94025, USA
| | - S. Grundmann
- Institut für Kernphysik, Goethe-Universität, Max-von-Laue-Straße 1, 60438 Frankfurt am Main, Germany
| | - P. Grychtol
- European XFEL, Holzkoppel 4, 22869 Schenefeld, Germany
| | - A. Hartung
- Institut für Kernphysik, Goethe-Universität, Max-von-Laue-Straße 1, 60438 Frankfurt am Main, Germany
| | - M. Hofmann
- Institut für Kernphysik, Goethe-Universität, Max-von-Laue-Straße 1, 60438 Frankfurt am Main, Germany
| | - M. Ilchen
- Institut für Physik und CINSaT, Universität Kassel, Heinrich-Plett-Straße 40, 34132 Kassel, Germany
- European XFEL, Holzkoppel 4, 22869 Schenefeld, Germany
| | - C. Janke
- Institut für Kernphysik, Goethe-Universität, Max-von-Laue-Straße 1, 60438 Frankfurt am Main, Germany
| | - M. Kircher
- Institut für Kernphysik, Goethe-Universität, Max-von-Laue-Straße 1, 60438 Frankfurt am Main, Germany
| | - M. Kunitski
- Institut für Kernphysik, Goethe-Universität, Max-von-Laue-Straße 1, 60438 Frankfurt am Main, Germany
| | - X. Li
- J.R. Macdonald Laboratory, Department of Physics, Kansas State University, Manhattan, Kansas 66506, USA
| | - T. Mazza
- European XFEL, Holzkoppel 4, 22869 Schenefeld, Germany
| | - N. Melzer
- Institut für Kernphysik, Goethe-Universität, Max-von-Laue-Straße 1, 60438 Frankfurt am Main, Germany
| | - J. Montano
- European XFEL, Holzkoppel 4, 22869 Schenefeld, Germany
| | - V. Music
- Institut für Physik und CINSaT, Universität Kassel, Heinrich-Plett-Straße 40, 34132 Kassel, Germany
- European XFEL, Holzkoppel 4, 22869 Schenefeld, Germany
| | - G. Nalin
- Institut für Kernphysik, Goethe-Universität, Max-von-Laue-Straße 1, 60438 Frankfurt am Main, Germany
| | - Y. Ovcharenko
- European XFEL, Holzkoppel 4, 22869 Schenefeld, Germany
| | - A. Pier
- Institut für Kernphysik, Goethe-Universität, Max-von-Laue-Straße 1, 60438 Frankfurt am Main, Germany
| | - N. Rennhack
- European XFEL, Holzkoppel 4, 22869 Schenefeld, Germany
| | - D. E. Rivas
- European XFEL, Holzkoppel 4, 22869 Schenefeld, Germany
| | - R. Dörner
- Institut für Kernphysik, Goethe-Universität, Max-von-Laue-Straße 1, 60438 Frankfurt am Main, Germany
| | - D. Rolles
- J.R. Macdonald Laboratory, Department of Physics, Kansas State University, Manhattan, Kansas 66506, USA
| | - A. Rudenko
- J.R. Macdonald Laboratory, Department of Physics, Kansas State University, Manhattan, Kansas 66506, USA
| | - Ph. Schmidt
- Institut für Physik und CINSaT, Universität Kassel, Heinrich-Plett-Straße 40, 34132 Kassel, Germany
- European XFEL, Holzkoppel 4, 22869 Schenefeld, Germany
| | - J. Siebert
- Institut für Kernphysik, Goethe-Universität, Max-von-Laue-Straße 1, 60438 Frankfurt am Main, Germany
| | - N. Strenger
- Institut für Kernphysik, Goethe-Universität, Max-von-Laue-Straße 1, 60438 Frankfurt am Main, Germany
| | - D. Trabert
- Institut für Kernphysik, Goethe-Universität, Max-von-Laue-Straße 1, 60438 Frankfurt am Main, Germany
| | - I. Vela-Perez
- Institut für Kernphysik, Goethe-Universität, Max-von-Laue-Straße 1, 60438 Frankfurt am Main, Germany
| | - R. Wagner
- European XFEL, Holzkoppel 4, 22869 Schenefeld, Germany
| | - Th. Weber
- Lawrence Berkeley National Laboratory, Chemical Sciences Division, Berkeley, California 94720, USA
| | - J. B. Williams
- Department of Physics, University of Nevada, Reno, Nevada 89557, USA
| | - P. Ziolkowski
- European XFEL, Holzkoppel 4, 22869 Schenefeld, Germany
| | - L. Ph. H. Schmidt
- Institut für Kernphysik, Goethe-Universität, Max-von-Laue-Straße 1, 60438 Frankfurt am Main, Germany
| | - A. Czasch
- Institut für Kernphysik, Goethe-Universität, Max-von-Laue-Straße 1, 60438 Frankfurt am Main, Germany
| | - Y. Tamura
- Department of Physics, University of Toyama, Gofuku 3190, Toyama 930-8555, Japan
| | - N. Hara
- Department of Physics, University of Toyama, Gofuku 3190, Toyama 930-8555, Japan
| | - K. Yamazaki
- RIKEN Center for Advanced Photonics, RIKEN, 2-1 Hirosawa, Wako, Saitama, 351-0198, Japan
| | - K. Hatada
- Department of Physics, University of Toyama, Gofuku 3190, Toyama 930-8555, Japan
| | - F. Trinter
- Deutsches Elektronen-Synchrotron DESY, Notkestraße 85, 22607 Hamburg, Germany
- Molecular Physics, Fritz-Haber-Institut der Max-Planck-Gesellschaft, Faradayweg 4-6, 14195 Berlin, Germany
| | - M. Meyer
- European XFEL, Holzkoppel 4, 22869 Schenefeld, Germany
| | - K. Ueda
- Institute of Multidisciplinary Research for Advanced Materials, Tohoku University, Katahira 2-1-1, Aoba-ku, Sendai 980-8577, Japan
- Department of Chemistry, Tohoku University, 6-3 Aramaki Aza-Aoba, Aoba-ku, Sendai, 980-8578, Japan
| | - Ph. V. Demekhin
- Institut für Physik und CINSaT, Universität Kassel, Heinrich-Plett-Straße 40, 34132 Kassel, Germany
| | - T. Jahnke
- European XFEL, Holzkoppel 4, 22869 Schenefeld, Germany
| |
Collapse
|
14
|
Boutin JA, Logez C, Damian M, Wagner R, Banères JL, Ferry G. MT1 Melatonin Receptor Reconstitution in Nanodiscs. Methods Mol Biol 2022; 2550:171-178. [PMID: 36180690 DOI: 10.1007/978-1-0716-2593-4_21] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/16/2023]
Abstract
A way to study G protein-coupled receptors in a minimal system is to reconstruct artificial membrane mimics, made of detergent and/or of lipids in which the purified receptor is maintained. In particular, it is now possible to generate lipid nanoparticles, such as nanodiscs, in which a single receptor molecule is included. Such objects offer the invaluable potential of studying an isolated receptor stabilized in a finely controlled membrane-like environment to evaluate its pharmacology, its function, and its structure at the molecular level. In this chapter, we detail the different steps from the extraction and isolation of a recombinant MT1 melatonin receptor in detergent, down to its reconstitution into nanodiscs. A G protein activation test is further described in order to exemplify how the functionality of such particles may be investigated.
Collapse
Affiliation(s)
- Jean A Boutin
- Pole d'expertise Biotechnologie, Chimie & Biologie, Institut de Recherches Servier, Croissy-sur-Seine, France.
- PHARMADEV (Pharmacochimie et biologie pour le développement), Faculté de Pharmacie, Toulouse, France.
| | - Christel Logez
- Pole d'expertise Biotechnologie, Chimie & Biologie, Institut de Recherches Servier, Croissy-sur-Seine, France
- Plateforme IMPReSs, Laboratoire de Biotechnologie et Signalisation Cellulaire, CNRS, Université de Strasbourg, Illkirch, France
- Bioprocess Research & Development, SANOFI PASTEUR, Marcy l'Etoile, France
| | - Marjorie Damian
- IBMM, Université de Montpellier, CNRS, ENSCM, Montpellier, France
| | - Renaud Wagner
- Plateforme IMPReSs, Laboratoire de Biotechnologie et Signalisation Cellulaire, CNRS, Université de Strasbourg, Illkirch, France
| | | | - Gilles Ferry
- Pole d'expertise Biotechnologie, Chimie & Biologie, Institut de Recherches Servier, Croissy-sur-Seine, France
| |
Collapse
|
15
|
Barret L, Schubeis T, Kugler V, Guyot L, Pintacuda G, Wagner R. Production and Preparation of Isotopically Labeled Human Membrane Proteins in Pichia pastoris for Fast-MAS-NMR Analyses. Methods Mol Biol 2022; 2507:201-221. [PMID: 35773584 DOI: 10.1007/978-1-0716-2368-8_11] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/15/2023]
Abstract
Membrane proteins (MPs) comprise about one-third of the human proteome, playing critical roles in many physiological processes and associated disorders. Consistently, they represent one of the largest classes of targets for the pharmaceutical industry. Their study at the molecular level is however particularly challenging, resulting in a severe lack of structural and dynamic information that is hindering their detailed functional characterization and the identification of novel potent drug candidates.Magic Angle Spinning (MAS) NMR is a reliable and efficient method for the determination of protein structures and dynamics and for the identification of ligand binding sites and equilibria. MAS-NMR is particularly well suited for MPs since they can be directly analysed in a native-like lipid bilayer environment but used to require aggravating large amounts of isotope enriched material. The frequent toxicity of human MP overexpression in bacterial cultures poses an additional hurdle, resulting in the need for alternative (and often more costly) expression systems. The recent development of very fast (up to 150 kHz) MAS probes has revolutionized the field of biomolecular solid-state NMR enabling higher spectral resolution with significant reduction of the required sample, rendering eukaryotic expression systems cost-effective.Here is presented a set of accessible procedures validated for the production and preparation of eukaryotic MPs for Fast-MAS 1H-detected NMR analysis. The methodology is illustrated with the human copper uptake protein hCTR1 recombinantly produced and 13C-15N uniformly labeled with the versatile and affordable Pichia pastoris system. Subsequent purification procedures allow the recovery of mg amounts that are then reconstituted into liposome formulations compatible with solid-state NMR handling and analysis.
Collapse
Affiliation(s)
- Lina Barret
- Biotechnology and Cell Signalling, IMPReSs Protein Facility, UMR7242 CNRS-University of Strasbourg, Illkirch, France
- Centre de Résonance Magnétique Nucléaire à Très Hauts Champs de Lyon (UMR 5082-CNRS, Université Claude Bernard Lyon 1, École Normale Supérieure Lyon), Université de Lyon, Villeurbanne, France
| | - Tobias Schubeis
- Centre de Résonance Magnétique Nucléaire à Très Hauts Champs de Lyon (UMR 5082-CNRS, Université Claude Bernard Lyon 1, École Normale Supérieure Lyon), Université de Lyon, Villeurbanne, France
| | - Valérie Kugler
- Biotechnology and Cell Signalling, IMPReSs Protein Facility, UMR7242 CNRS-University of Strasbourg, Illkirch, France
| | - Lucile Guyot
- Biotechnology and Cell Signalling, IMPReSs Protein Facility, UMR7242 CNRS-University of Strasbourg, Illkirch, France
- NovAliX, Illkirch, France
| | - Guido Pintacuda
- Centre de Résonance Magnétique Nucléaire à Très Hauts Champs de Lyon (UMR 5082-CNRS, Université Claude Bernard Lyon 1, École Normale Supérieure Lyon), Université de Lyon, Villeurbanne, France
| | - Renaud Wagner
- Biotechnology and Cell Signalling, IMPReSs Protein Facility, UMR7242 CNRS-University of Strasbourg, Illkirch, France.
| |
Collapse
|
16
|
Wagner R, Fieseler H, Kaiser M, Müller H, Mielenz N, Spilke J, Gottschalk J, Einspanier A, Palme R, Rizk A, Möbius G, Baumgartner W, Rachidi F, Starke A. [Cortisol concentrations in sheep before, during and after sham foot trimming on a tilt table - the suitability of different matrices]. SCHWEIZ ARCH TIERH 2021; 164:753-766. [PMID: 34758951 DOI: 10.17236/sat00325] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Abstract
INTRODUCTION Matrices that can be collected non-invasively for quantification of a stress response in sheep have received little attention in the veterinary literature. This study examines the suitability of blood, tears and saliva for determining a stress response in sheep undergoing sham foot trimming on a tilt table. The cortisol concentration of blood, tears and saliva and the concentration of cortisol metabolites in faeces were measured in 13 healthy Meat Merino ewes once a day for six days. Sham foot trimming on a tilt table was used as the stressor and was done during a one-hour period on day 4; cortisol concentrations of blood and tears were measured at 0, 10, 20, 30, 40 and 60 minutes. Cortisol concentrations of blood (maximum at 30 minutes) and tears (maximum at 40 minutes) increased during the procedure and then decreased. There were significant correlations between cortisol concentrations of blood and tears (p = 0,04) during sham foot trimming (area under the curve, 0 to 60 minutes). Over the entire 6-day study period, significant correlations were seen between the cortisol concentrations of blood and tears (r = 0,55; p.
Collapse
Affiliation(s)
- R Wagner
- Klinik für Klauentiere, Veterinärmedizinische Fakultät, Universität Leipzig, Deutschland
| | - H Fieseler
- Klinik für Klauentiere, Veterinärmedizinische Fakultät, Universität Leipzig, Deutschland
| | - M Kaiser
- Klinik für Klauentiere, Veterinärmedizinische Fakultät, Universität Leipzig, Deutschland
| | - H Müller
- Klinik für Klauentiere, Veterinärmedizinische Fakultät, Universität Leipzig, Deutschland
| | - N Mielenz
- Institut für -Agrar- und Ernährungswissenschaften, Arbeitsgruppe Biometrie und Agrarinformatik, Martin-Luther-Universität, Halle-Wittenberg, 06120 Halle (Saale), Deutschland
| | - J Spilke
- Institut für -Agrar- und Ernährungswissenschaften, Arbeitsgruppe Biometrie und Agrarinformatik, Martin-Luther-Universität, Halle-Wittenberg, 06120 Halle (Saale), Deutschland
| | - J Gottschalk
- Veterinär-Physiologisch-Chemisches Institut, Biochemie der Veterinär-medizinischen Fakultät, Universität Leipzig, Deutschland
| | - A Einspanier
- Veterinär-Physiologisch-Chemisches Institut, Biochemie der Veterinär-medizinischen Fakultät, Universität Leipzig, Deutschland
| | - R Palme
- Abteilung für Physiologie, Pathophysiologie und -experimentelle Endokrinologie, Veterinärmedizinische Universität Wien, Österreich
| | - A Rizk
- Abteilung Chirurgie, -Anästhesiologie und Radiologie, Veterinärmedizinische Fakultät, Universität Mansoura, Ägypten
| | - G Möbius
- Institut für Tierhygiene und Öffentliches Veterinärwesen der Veterinärmedizinischen Fakultät der Universität Leipzig, Deutschland
| | - W Baumgartner
- Universitätsklinik für Wiederkäuer, Veterinärmedizinische Universität Wien, Wien, Österreich
| | - F Rachidi
- Klinik für Klauentiere, Veterinärmedizinische Fakultät, Universität Leipzig, Deutschland
| | - A Starke
- Klinik für Klauentiere, Veterinärmedizinische Fakultät, Universität Leipzig, Deutschland
| |
Collapse
|
17
|
Naetzold S, Viégas J, Skonieski F, Tonin T, Schumacher L, Fagundes M, Rocha L, Wagner R. Fractionation of carbohydrates and proteins and in vitro rumen kinetics of corn silage under various storage durations. S AFR J ANIM SCI 2021. [DOI: 10.4314/sajas.v51i4.13] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
The experiment evaluated the effects on the chemical composition (fermentation, kinetic parameters, and protein and carbohydrate fractions) of corn silage after various storage durations (45, 90, 180, and 360 days). Experimental mini silos of the corn plants were made and opened after various storage periods. The experimental design was completely randomized with four treatments and four replications per treatment. Variables such as pH, lactic acid and acetic acid showed a quadratic effect, whereas effluent and gas losses increased linearly with prolonged storage. Proteolysis was observed with an increase in storage, resulting in a rise in ammonia-N, soluble N, and non-protein N concentration and reduction in true protein. The soluble carbohydrate fractions were reduced, and digestible and indigestible fibre were increased. For the kinetic degradation parameters of the silages obtained through in vitro gas methodology, the highest fermentation rate occurred in the first 12 hours of incubation, and the highest volume of gas produced within 96 hours was obtained for silages with shorter storage (45 days). The increase in storage resulted in greater losses and lower ruminal degradability in vitro, causing a decrease in protein quality and nutritional value.
Collapse
|
18
|
Mustafá ER, Cordisco González S, Damian M, Cantel S, Denoyelle S, Wagner R, Schiöth HB, Fehrentz JA, Banères JL, Perelló M, Raingo J. LEAP2 Impairs the Capability of the Growth Hormone Secretagogue Receptor to Regulate the Dopamine 2 Receptor Signaling. Front Pharmacol 2021; 12:712437. [PMID: 34447311 PMCID: PMC8383165 DOI: 10.3389/fphar.2021.712437] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/20/2021] [Accepted: 07/26/2021] [Indexed: 12/12/2022] Open
Abstract
The growth hormone secretagogue receptor (GHSR) signals in response to ghrelin, but also acts via ligand-independent mechanisms that include either constitutive activation or interaction with other G protein-coupled receptors, such as the dopamine 2 receptor (D2R). A key target of GHSR in neurons is voltage-gated calcium channels type 2.2 (CaV2.2). Recently, the liver-expressed antimicrobial peptide 2 (LEAP2) was recognized as a novel GHSR ligand, but the mechanism of action of LEAP2 on GHSR is not well understood. Here, we investigated the role of LEAP2 on the canonical and non-canonical modes of action of GHSR on CaV2.2 function. Using a heterologous expression system and patch-clamp recordings, we found that LEAP2 impairs the reduction of CaV2.2 currents induced by ghrelin-evoked and constitutive GHSR activities, acting as a GHSR antagonist and inverse agonist, respectively. We also found that LEAP2 prevents GHSR from modulating the effects of D2R signaling on CaV2.2 currents, and that the GHSR-binding N-terminal region LEAP2 underlies these effects. Using purified labeled receptors assembled into lipid nanodiscs and Forster Resonance Energy Transfer (FRET) assessments, we found that the N-terminal region of LEAP2 stabilizes an inactive conformation of GHSR that is dissociated from Gq protein and, consequently, reverses the effect of GHSR on D2R-dependent Gi activation. Thus, our results provide critical molecular insights into the mechanism mediating LEAP2 modulation of GHSR.
Collapse
Affiliation(s)
- Emilio R Mustafá
- Laboratory of Electrophysiology of the Multidisciplinary Institute of Cell Biology [IMBICE, Argentine Research Council (CONICET) and Scientific Research Commission, Province of Buenos Aires (CIC-PBA), National University of La Plata (UNLP)], La Plata, Argentina
| | - Santiago Cordisco González
- Laboratory of Electrophysiology of the Multidisciplinary Institute of Cell Biology [IMBICE, Argentine Research Council (CONICET) and Scientific Research Commission, Province of Buenos Aires (CIC-PBA), National University of La Plata (UNLP)], La Plata, Argentina
| | - Marjorie Damian
- Institut des Biomolécules Max Mousseron (IBMM), Université Montpellier, CNRS, Montpellier, France
| | - Sonia Cantel
- Institut des Biomolécules Max Mousseron (IBMM), Université Montpellier, CNRS, Montpellier, France
| | - Severine Denoyelle
- Institut des Biomolécules Max Mousseron (IBMM), Université Montpellier, CNRS, Montpellier, France
| | - Renaud Wagner
- Plateforme IMPReSs, CNRS UMR7242, Biotechnologie et Signalisation Cellulaire, École Supérieure de Biotechnologie de Strasbourg, Strasbourg, France
| | - Helgi B Schiöth
- Department of Neuroscience, Uppsala University, Uppsala, Sweden.,Institute for Translational Medicine and Biothechnology, I. M. Sechenov First Moscow State Medical University, Moscow, Russia
| | - Jean-Alain Fehrentz
- Institut des Biomolécules Max Mousseron (IBMM), Université Montpellier, CNRS, Montpellier, France
| | - Jean-Louis Banères
- Institut des Biomolécules Max Mousseron (IBMM), Université Montpellier, CNRS, Montpellier, France
| | - Mario Perelló
- Laboratory of Neurophysiology of the Multidisciplinary Institute of Cell Biology [IMBICE, Argentine Research Council (CONICET) and Scientific Research Commission, Province of Buenos Aires (CIC-PBA), National University of La Plata (UNLP)], La Plata, Argentina
| | - Jesica Raingo
- Laboratory of Electrophysiology of the Multidisciplinary Institute of Cell Biology [IMBICE, Argentine Research Council (CONICET) and Scientific Research Commission, Province of Buenos Aires (CIC-PBA), National University of La Plata (UNLP)], La Plata, Argentina
| |
Collapse
|
19
|
Hedberg YS, Wei Z, McCarrick S, Romanovski V, Theodore J, Westin EM, Wagner R, Persson KA, Karlsson HL, Odnevall Wallinder I. Welding fume nanoparticles from solid and flux-cored wires: Solubility, toxicity, and role of fluorides. J Hazard Mater 2021; 413:125273. [PMID: 33581669 DOI: 10.1016/j.jhazmat.2021.125273] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/13/2020] [Revised: 01/21/2021] [Accepted: 01/27/2021] [Indexed: 05/28/2023]
Abstract
Welding fume particles are hazardous. Their toxicity likely depends on their composition and reactivity. This study aimed at exploring the role of sodium or other fluorides (NaF), which are intentionally added to flux-cored wire electrodes for stainless steel welding, on the solubility (in phosphate buffered saline) and toxicity of the generated welding fume particles. A multi-analytical particle characterization approach along with in-vitro cell assays was undertaken. The release of Cr(VI) and Mn from the particles was tested as a function of fluoride solution concentration. The welding fume particles containing NaF released significantly higher amounts of Cr(VI) compared with solid wire reference fumes, which was associated with increased cytotoxicity and genotoxicity in-vitro. No crystalline Na or potassium (K) containing chromates were observed. Cr(VI) was incorporated in an amorphous mixed oxide. Solution-added fluorides did not increase the solubility of Cr(VI), but contributed to a reduced Mn release from both solid and flux-cored wire fume particles and the reduction of Cr(VI) release from solid wire fume particles. Chemical speciation modeling suggested that metal fluoride complexes were not formed. The presence of NaF in the welding electrodes did not have any direct, but possibly an indirect, role in the Cr(VI) solubility of welding fumes.
Collapse
Affiliation(s)
- Y S Hedberg
- KTH Royal Institute of Technology, Department of Chemistry, Division of Surface and Corrosion Science, 10044 Stockholm, Sweden; Department of Chemistry, The University of Western Ontario, London, Ontario N6A 3K7, Canada; Surface Science Western, The University of Western Ontario, London, Ontario N6G 0J3, Canada.
| | - Z Wei
- KTH Royal Institute of Technology, Department of Chemistry, Division of Surface and Corrosion Science, 10044 Stockholm, Sweden
| | - S McCarrick
- Institute of Environmental Medicine, Karolinska Institutet, 171 77 Stockholm, Sweden
| | - V Romanovski
- KTH Royal Institute of Technology, Department of Chemistry, Division of Surface and Corrosion Science, 10044 Stockholm, Sweden; Center of Functional Nano-Ceramics, National University of Science and Technology "MISIS", 119049 Moscow, Russia; Institute of General and Inorganic Chemistry, National Academy of Sciences of Belarus, 220072 Minsk, Belarus
| | - J Theodore
- KTH Royal Institute of Technology, Department of Chemistry, Division of Surface and Corrosion Science, 10044 Stockholm, Sweden
| | - E M Westin
- voestalpine Böhler Welding Group GmbH, Böhler-Welding-Str. 1, 8605 Kapfenberg, Austria
| | - R Wagner
- Linde GmbH/UniBw Munich, Germany
| | | | - H L Karlsson
- Institute of Environmental Medicine, Karolinska Institutet, 171 77 Stockholm, Sweden
| | - I Odnevall Wallinder
- KTH Royal Institute of Technology, Department of Chemistry, Division of Surface and Corrosion Science, 10044 Stockholm, Sweden; AIMES - Center for the Advancement of Integrated Medical and Engineering Sciences at Karolinska Institutet and KTH Royal Institute of Technology, Stockholm, Sweden; Department of Neuroscience, Karolinska Institutet, SE-171 77 Stockholm, Sweden.
| |
Collapse
|
20
|
Wagner R, Sonnek G, Wüstneck R, Jänicke A, Herbst M, Richter L, Engelbrecht L. Interfacial behaviour of silicone surfactants. TENSIDE SURFACT DET 2021. [DOI: 10.1515/tsd-1994-310518] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
21
|
Zuniga D, Bendahhou S, Bonneté F, Bouceba T, Pozza A, Wagner R, Venien‐Bryan C. Structural and Functional Characterization of a Human Potassium Channel, Kir2.1. FASEB J 2021. [DOI: 10.1096/fasebj.2021.35.s1.04829] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
| | | | | | | | | | - Renaud Wagner
- IMPReSs Facility, Biotechnology and Cell Signaling, CNRS UMR7242Université de StrasbourgStrasbourg
| | | |
Collapse
|
22
|
Eichmann U, Rottke H, Meise S, Rubensson JE, Söderström J, Agåker M, Såthe C, Meyer M, Baumann TM, Boll R, De Fanis A, Grychtol P, Ilchen M, Mazza T, Montano J, Music V, Ovcharenko Y, Rivas DE, Serkez S, Wagner R, Eisebitt S. Photon-recoil imaging: Expanding the view of nonlinear x-ray physics. Science 2020; 369:1630-1633. [PMID: 32973029 DOI: 10.1126/science.abc2622] [Citation(s) in RCA: 14] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/15/2020] [Accepted: 07/02/2020] [Indexed: 11/02/2022]
Abstract
Addressing the ultrafast coherent evolution of electronic wave functions has long been a goal of nonlinear x-ray physics. A first step toward this goal is the investigation of stimulated x-ray Raman scattering (SXRS) using intense pulses from an x-ray free-electron laser. Earlier SXRS experiments relied on signal amplification during pulse propagation through dense resonant media. By contrast, our method reveals the fundamental process in which photons from the primary radiation source directly interact with a single atom. We introduce an experimental protocol in which scattered neutral atoms rather than scattered photons are detected. We present SXRS measurements at the neon K edge and a quantitative theoretical analysis. The method should become a powerful tool in the exploration of nonlinear x-ray physics.
Collapse
Affiliation(s)
- U Eichmann
- Max Born Institute, 12489 Berlin, Germany.
| | - H Rottke
- Max Born Institute, 12489 Berlin, Germany
| | - S Meise
- Max Born Institute, 12489 Berlin, Germany
| | - J-E Rubensson
- Department of Physics and Astronomy, Uppsala University, SE-751 20 Uppsala, Sweden
| | - J Söderström
- Department of Physics and Astronomy, Uppsala University, SE-751 20 Uppsala, Sweden
| | - M Agåker
- Department of Physics and Astronomy, Uppsala University, SE-751 20 Uppsala, Sweden.,MAX IV Laboratory, Lund University, SE-221 00 Lund, Sweden
| | - C Såthe
- MAX IV Laboratory, Lund University, SE-221 00 Lund, Sweden
| | - M Meyer
- European XFEL, 22869 Schenefeld, Germany
| | | | - R Boll
- European XFEL, 22869 Schenefeld, Germany
| | - A De Fanis
- European XFEL, 22869 Schenefeld, Germany
| | - P Grychtol
- European XFEL, 22869 Schenefeld, Germany
| | - M Ilchen
- European XFEL, 22869 Schenefeld, Germany.,Institut für Physik, University of Kassel, 34132 Kassel, Germany
| | - T Mazza
- European XFEL, 22869 Schenefeld, Germany
| | - J Montano
- European XFEL, 22869 Schenefeld, Germany
| | - V Music
- European XFEL, 22869 Schenefeld, Germany.,Institut für Physik, University of Kassel, 34132 Kassel, Germany
| | | | - D E Rivas
- European XFEL, 22869 Schenefeld, Germany
| | - S Serkez
- European XFEL, 22869 Schenefeld, Germany
| | - R Wagner
- European XFEL, 22869 Schenefeld, Germany
| | - S Eisebitt
- Max Born Institute, 12489 Berlin, Germany.,Institut für Optik und Atomare Physik, Technische Universität Berlin, 10623 Berlin, Germany
| |
Collapse
|
23
|
Valentini J, Da Silva A, Fortuoso B, Reis J, Gebert R, Griss L, Boiago M, Lopes L, Santos R, Wagner R, Tavernari F. Chemical composition, lipid peroxidation, and fatty acid profile in meat of broilers fed with glycerol monolaurate additive. Food Chem 2020; 330:127187. [DOI: 10.1016/j.foodchem.2020.127187] [Citation(s) in RCA: 17] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/06/2020] [Revised: 05/03/2020] [Accepted: 05/28/2020] [Indexed: 12/17/2022]
|
24
|
Ferro E, Abrahams-Gessel S, Wagner R, Montana L, Gomez-Olive X, Tollman S, Gaziano T. Defining the electrocardiographic and echocardiographic abnormalities in a population of older adults with cardiovascular disease in rural south africa. Eur Heart J 2020. [DOI: 10.1093/ehjci/ehaa946.2739] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
The African continent is undergoing an epidemiologic transition from infectious to cardiovascular (CV) diseases. National health systems face a critical shortage of population-level data to target the growing burden of hypertension (HTN). Very little is known on the impact of HTN on the rural population in many African countries, where over 85% of the rural population will migrate to cities and shape the modern CV disease spectrum of Africa in the next decade.
Purpose
To characterize the prevalence of HTN and HTN-related EKG and TTE abnormalities in a rural cohort in South Africa (n=5,059).
Methods
Between 2014 and 2015, 804 EKGs and 158 TTEs were performed on participants aged 40 or older randomly sampled from a longitudinal cohort residing in the Agincourt sub-district of rural South Africa. EKGs and TTEs were interpreted by two blinded physicians, and clinically meaningful variables defined using the Minnesota code (EKG) and European Association of Cardiovascular Imaging guidelines (TTE). Chi-square tests were conducted to define the association of EKG/TTE abnormalities with HTN, and stratify by gender.
Results
Over 55% of the sample (n=810) met blood pressure criteria for HTN, with a high prevalence of obesity (29%). On EKG, 36.5% participants had left ventricular hypertrophy (LVH), 13.6% T wave abnormalities, 7.5% Q wave abnormalities and 18.8% prolonged QT interval. Males (n=291) had more LVH (45% vs 30.8%, p<0.01) and Q wave abnormalities (10% vs 5.9%, p=0.04) than females. Instead, females (n=438) had more prolonged QT intervals (28.8% vs 21%, p=0.02). Compared to those without HTN, participants with HTN had more LVH (45.4% vs 22.1%, p<0.01), ST segment abnormalities (17.4% vs 10.7%, p<0.01) and prolonged QT interval (23.4% vs 11.4%, p<0.01). On TTE, there was a high prevalence of moderate (31%) / severe (25.8%) diastolic dysfunction, and concentric LVH (31.6%). Females had more concentric LVH (40.8% vs 13.5%, p<0.01), and high relative wall thickness (70% vs 18.1%, p<0.01) than males. Participants with HTN had more concentric LVH (42.5% vs 8.2%, p<0.01), LV mass (58.5% vs 20.4%, p<0.01) and LV mass index (52.8% vs 30.6%, p<0.01), than those without HTN.
Conclusions
The rural population in South Africa is already affected by a high burden of HTN and high obesity levels. Within this cohort, patients with HTN have significantly more EKG and TTE abnormalities that predict adverse CV outcomes. EKG and TTE evaluation can be used to identify high-risk groups that national health systems should prioritize with frequent monitoring and more aggressive medical treatment.
Funding Acknowledgement
Type of funding source: Private hospital(s). Main funding source(s): Brigham and Women's Hospital
Collapse
Affiliation(s)
- E.G Ferro
- Brigham and Women'S Hospital, Harvard Medical School, Boston, United States of America
| | - S Abrahams-Gessel
- Brigham and Women'S Hospital, Harvard Medical School, Boston, United States of America
| | - R Wagner
- University of the Witwatersrand, Johannesburg, South Africa
| | - L Montana
- Harvard T. H. Chan School of Public Health, Boston, United States of America
| | - X Gomez-Olive
- University of the Witwatersrand, Johannesburg, South Africa
| | - S Tollman
- University of the Witwatersrand, Johannesburg, South Africa
| | - T Gaziano
- Brigham and Women'S Hospital, Harvard Medical School, Boston, United States of America
| |
Collapse
|
25
|
Hueck U, Muggenthaler H, Hubig M, Heinrich A, Güttler F, Wagner R, Mall G, Teichgräber U. Forensic postmortem computed tomography in suspected unnatural adult deaths. Eur J Radiol 2020; 132:109297. [PMID: 33035918 DOI: 10.1016/j.ejrad.2020.109297] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/03/2020] [Revised: 09/04/2020] [Accepted: 09/18/2020] [Indexed: 01/16/2023]
Abstract
PURPOSE Our study sought to evaluate validity of forensic postmortem CT in establishing cause of death (COD) in suspected unnatural adult death based on the reference standard of autopsy. METHODS In our prospective, single-center study, 64 of 94 consecutive corpses (70.7 % male, mean age: 47.4 years) who underwent CT and autopsy between November 2013 and April 2019 were included in the analysis. Primary objective was agreement between CT and autopsy on primary COD using kappa statistics. Secondary objectives were competing COD and specific pathological findings. RESULTS Agreement on primary COD between forensic CT and autopsy without or in consideration of toxicological and histological findings was strong (85.9 % [55 of 64 corpses]; κ = 0.83 [95 %CI: 0.74 to 0.93] and 95.3 % [61 of 64 corpses]; κ = 0.94 [95 %CI: 0.84-1.04], respectively, McNemar p = 0.03). Sensitivity and specificity of CT in identification of acute heart failure, intracranial bleeding, burns and heat shocks, gunshot wounds, polytrauma, cranio-cerebral trauma, and strangulation or hanging was 100 %, each. Acute respiratory failure was detected with a sensitivity and specificity of 100 % and 96.8 %, cuts and stab wounds with 95.2 % and 100 %, and intoxication, pneumonia, or gastrointestinal bleeding with 60.0 % and 100 %, respectively. Agreement on competing COD was moderate (51.6 %, [33 of 64 corpses]; κ = 0.47 [95 %CI: 0.40 to 0.53], p < 0.001). CONCLUSIONS Forensic postmortem CT, complemented by external, toxicological, and histological examination was sufficiently valid to assess primary COD in the majority of suspected unnatural deaths with few restrictions.
Collapse
Affiliation(s)
- U Hueck
- Department of Radiology, Jena University Hospital, Am Klinikum 1, 07747, Jena, Germany
| | - H Muggenthaler
- Department of Forensic Medicine, Jena University Hospital, Jena, Am Klinikum 1, 07747, Jena, Germany
| | - M Hubig
- Department of Forensic Medicine, Jena University Hospital, Jena, Am Klinikum 1, 07747, Jena, Germany
| | - A Heinrich
- Department of Radiology, Jena University Hospital, Am Klinikum 1, 07747, Jena, Germany
| | - F Güttler
- Department of Radiology, Jena University Hospital, Am Klinikum 1, 07747, Jena, Germany
| | - R Wagner
- Department of Forensic Medicine, Jena University Hospital, Jena, Am Klinikum 1, 07747, Jena, Germany
| | - G Mall
- Department of Forensic Medicine, Jena University Hospital, Jena, Am Klinikum 1, 07747, Jena, Germany
| | - U Teichgräber
- Department of Radiology, Jena University Hospital, Am Klinikum 1, 07747, Jena, Germany.
| |
Collapse
|
26
|
Yan C, Nie W, Vogel AL, Dada L, Lehtipalo K, Stolzenburg D, Wagner R, Rissanen MP, Xiao M, Ahonen L, Fischer L, Rose C, Bianchi F, Gordon H, Simon M, Heinritzi M, Garmash O, Roldin P, Dias A, Ye P, Hofbauer V, Amorim A, Bauer PS, Bergen A, Bernhammer AK, Breitenlechner M, Brilke S, Buchholz A, Mazon SB, Canagaratna MR, Chen X, Ding A, Dommen J, Draper DC, Duplissy J, Frege C, Heyn C, Guida R, Hakala J, Heikkinen L, Hoyle CR, Jokinen T, Kangasluoma J, Kirkby J, Kontkanen J, Kürten A, Lawler MJ, Mai H, Mathot S, Mauldin RL, Molteni U, Nichman L, Nieminen T, Nowak J, Ojdanic A, Onnela A, Pajunoja A, Petäjä T, Piel F, Quéléver LLJ, Sarnela N, Schallhart S, Sengupta K, Sipilä M, Tomé A, Tröstl J, Väisänen O, Wagner AC, Ylisirniö A, Zha Q, Baltensperger U, Carslaw KS, Curtius J, Flagan RC, Hansel A, Riipinen I, Smith JN, Virtanen A, Winkler PM, Donahue NM, Kerminen VM, Kulmala M, Ehn M, Worsnop DR. Size-dependent influence of NO x on the growth rates of organic aerosol particles. Sci Adv 2020; 6:eaay4945. [PMID: 32518819 PMCID: PMC7253163 DOI: 10.1126/sciadv.aay4945] [Citation(s) in RCA: 22] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/01/2019] [Accepted: 03/19/2020] [Indexed: 05/24/2023]
Abstract
Atmospheric new-particle formation (NPF) affects climate by contributing to a large fraction of the cloud condensation nuclei (CCN). Highly oxygenated organic molecules (HOMs) drive the early particle growth and therefore substantially influence the survival of newly formed particles to CCN. Nitrogen oxide (NOx) is known to suppress the NPF driven by HOMs, but the underlying mechanism remains largely unclear. Here, we examine the response of particle growth to the changes of HOM formation caused by NOx. We show that NOx suppresses particle growth in general, but the suppression is rather nonuniform and size dependent, which can be quantitatively explained by the shifted HOM volatility after adding NOx. By illustrating how NOx affects the early growth of new particles, a critical step of CCN formation, our results help provide a refined assessment of the potential climatic effects caused by the diverse changes of NOx level in forest regions around the globe.
Collapse
Affiliation(s)
- C. Yan
- Institute for Atmospheric and Earth System Research/INAR–Physics, Faculty of Science, University of Helsinki, 00560 Helsinki, Finland
| | - W. Nie
- Joint International Research Laboratory of Atmospheric and Earth System Sciences, School of Atmospheric Sciences, Nanjing University, Nanjing, China
| | - A. L. Vogel
- CERN, CH-1211, Geneva, Switzerland
- Laboratory of Atmospheric Chemistry, Paul Scherrer Institute, 5232 Villigen, Switzerland
| | - L. Dada
- Institute for Atmospheric and Earth System Research/INAR–Physics, Faculty of Science, University of Helsinki, 00560 Helsinki, Finland
| | - K. Lehtipalo
- Institute for Atmospheric and Earth System Research/INAR–Physics, Faculty of Science, University of Helsinki, 00560 Helsinki, Finland
- Laboratory of Atmospheric Chemistry, Paul Scherrer Institute, 5232 Villigen, Switzerland
- Finnish Meteorological Institute, Erik Palménin aukio 1, 00560 Helsinki, Finland
| | - D. Stolzenburg
- University of Vienna, Faculty of Physics, Boltzmanngasse 5, 1090 Wien, Austria
| | - R. Wagner
- Institute for Atmospheric and Earth System Research/INAR–Physics, Faculty of Science, University of Helsinki, 00560 Helsinki, Finland
| | - M. P. Rissanen
- Institute for Atmospheric and Earth System Research/INAR–Physics, Faculty of Science, University of Helsinki, 00560 Helsinki, Finland
| | - M. Xiao
- Laboratory of Atmospheric Chemistry, Paul Scherrer Institute, 5232 Villigen, Switzerland
| | - L. Ahonen
- Institute for Atmospheric and Earth System Research/INAR–Physics, Faculty of Science, University of Helsinki, 00560 Helsinki, Finland
| | - L. Fischer
- University of Innsbruck, Institute for Ion and Applied Physics, 6020 Innsbruck, Austria
| | - C. Rose
- Institute for Atmospheric and Earth System Research/INAR–Physics, Faculty of Science, University of Helsinki, 00560 Helsinki, Finland
| | - F. Bianchi
- Institute for Atmospheric and Earth System Research/INAR–Physics, Faculty of Science, University of Helsinki, 00560 Helsinki, Finland
- Aerosol and Haze Laboratory, Beijing Advanced Innovation Center for Soft Matter Science and Engineering, Beijing University of Chemical Technology, Beijing, China
| | - H. Gordon
- CERN, CH-1211, Geneva, Switzerland
- University of Leeds, Leeds LS2 9JT, UK
| | - M. Simon
- Goethe University Frankfurt, Institute for Atmospheric and Environmental Sciences, Altenhöferallee 1, 60438 Frankfurt am Main, Germany
| | - M. Heinritzi
- Goethe University Frankfurt, Institute for Atmospheric and Environmental Sciences, Altenhöferallee 1, 60438 Frankfurt am Main, Germany
| | - O. Garmash
- Institute for Atmospheric and Earth System Research/INAR–Physics, Faculty of Science, University of Helsinki, 00560 Helsinki, Finland
| | - P. Roldin
- Division of Nuclear Physics, Department of Physics, Lund University, P. O. Box 118, SE-221 00 Lund, Sweden
| | - A. Dias
- CERN, CH-1211, Geneva, Switzerland
- CENTRA and FCUL, Universidade de Lisboa, Campo Grande, 1749-016 Lisboa, Portugal
| | - P. Ye
- Carnegie Mellon University Center for Atmospheric Particle Studies, 5000 Forbes Ave., Pittsburgh, PA 15213, USA
- Aerodyne Research Inc., Billerica, MA 01821, USA
| | - V. Hofbauer
- Carnegie Mellon University Center for Atmospheric Particle Studies, 5000 Forbes Ave., Pittsburgh, PA 15213, USA
| | - A. Amorim
- CENTRA and FCUL, Universidade de Lisboa, Campo Grande, 1749-016 Lisboa, Portugal
| | - P. S. Bauer
- University of Vienna, Faculty of Physics, Boltzmanngasse 5, 1090 Wien, Austria
| | - A. Bergen
- Goethe University Frankfurt, Institute for Atmospheric and Environmental Sciences, Altenhöferallee 1, 60438 Frankfurt am Main, Germany
| | - A.-K. Bernhammer
- University of Innsbruck, Institute for Ion and Applied Physics, 6020 Innsbruck, Austria
| | - M. Breitenlechner
- University of Innsbruck, Institute for Ion and Applied Physics, 6020 Innsbruck, Austria
| | - S. Brilke
- University of Vienna, Faculty of Physics, Boltzmanngasse 5, 1090 Wien, Austria
- Goethe University Frankfurt, Institute for Atmospheric and Environmental Sciences, Altenhöferallee 1, 60438 Frankfurt am Main, Germany
| | - A. Buchholz
- University of Eastern Finland, Department of Applied Physics, P.O. Box 1627, 70211 Kuopio, Finland
| | - S. Buenrostro Mazon
- Institute for Atmospheric and Earth System Research/INAR–Physics, Faculty of Science, University of Helsinki, 00560 Helsinki, Finland
| | | | - X. Chen
- Institute for Atmospheric and Earth System Research/INAR–Physics, Faculty of Science, University of Helsinki, 00560 Helsinki, Finland
| | - A. Ding
- Joint International Research Laboratory of Atmospheric and Earth System Sciences, School of Atmospheric Sciences, Nanjing University, Nanjing, China
| | - J. Dommen
- Laboratory of Atmospheric Chemistry, Paul Scherrer Institute, 5232 Villigen, Switzerland
| | - D. C. Draper
- Department of Chemistry, University of California, Irvine, CA 92697, USA
| | - J. Duplissy
- Institute for Atmospheric and Earth System Research/INAR–Physics, Faculty of Science, University of Helsinki, 00560 Helsinki, Finland
| | - C. Frege
- Laboratory of Atmospheric Chemistry, Paul Scherrer Institute, 5232 Villigen, Switzerland
| | - C. Heyn
- Laboratory of Atmospheric Chemistry, Paul Scherrer Institute, 5232 Villigen, Switzerland
| | - R. Guida
- CERN, CH-1211, Geneva, Switzerland
| | - J. Hakala
- Institute for Atmospheric and Earth System Research/INAR–Physics, Faculty of Science, University of Helsinki, 00560 Helsinki, Finland
| | - L. Heikkinen
- Institute for Atmospheric and Earth System Research/INAR–Physics, Faculty of Science, University of Helsinki, 00560 Helsinki, Finland
| | - C. R. Hoyle
- Laboratory of Atmospheric Chemistry, Paul Scherrer Institute, 5232 Villigen, Switzerland
| | - T. Jokinen
- Institute for Atmospheric and Earth System Research/INAR–Physics, Faculty of Science, University of Helsinki, 00560 Helsinki, Finland
| | - J. Kangasluoma
- Institute for Atmospheric and Earth System Research/INAR–Physics, Faculty of Science, University of Helsinki, 00560 Helsinki, Finland
- Aerosol and Haze Laboratory, Beijing Advanced Innovation Center for Soft Matter Science and Engineering, Beijing University of Chemical Technology, Beijing, China
| | - J. Kirkby
- CERN, CH-1211, Geneva, Switzerland
- Goethe University Frankfurt, Institute for Atmospheric and Environmental Sciences, Altenhöferallee 1, 60438 Frankfurt am Main, Germany
| | - J. Kontkanen
- Institute for Atmospheric and Earth System Research/INAR–Physics, Faculty of Science, University of Helsinki, 00560 Helsinki, Finland
| | - A. Kürten
- Goethe University Frankfurt, Institute for Atmospheric and Environmental Sciences, Altenhöferallee 1, 60438 Frankfurt am Main, Germany
| | - M. J. Lawler
- Department of Chemistry, University of California, Irvine, CA 92697, USA
| | - H. Mai
- California Institute of Technology, 210-41, Pasadena, CA 91125, USA
| | | | - R. L. Mauldin
- Carnegie Mellon University Center for Atmospheric Particle Studies, 5000 Forbes Ave., Pittsburgh, PA 15213, USA
- Department of Chemistry and Biochemistry, University of Colorado, Boulder, CO 80309, USA
| | - U. Molteni
- Laboratory of Atmospheric Chemistry, Paul Scherrer Institute, 5232 Villigen, Switzerland
| | - L. Nichman
- School of Earth and Environmental Science, University of Manchester, Manchester M13 9PL, UK
| | - T. Nieminen
- Institute for Atmospheric and Earth System Research/INAR–Physics, Faculty of Science, University of Helsinki, 00560 Helsinki, Finland
| | - J. Nowak
- Aerodyne Research Inc., Billerica, MA 01821, USA
| | - A. Ojdanic
- University of Vienna, Faculty of Physics, Boltzmanngasse 5, 1090 Wien, Austria
| | | | - A. Pajunoja
- University of Eastern Finland, Department of Applied Physics, P.O. Box 1627, 70211 Kuopio, Finland
| | - T. Petäjä
- Institute for Atmospheric and Earth System Research/INAR–Physics, Faculty of Science, University of Helsinki, 00560 Helsinki, Finland
- Joint International Research Laboratory of Atmospheric and Earth System Sciences, School of Atmospheric Sciences, Nanjing University, Nanjing, China
| | - F. Piel
- Goethe University Frankfurt, Institute for Atmospheric and Environmental Sciences, Altenhöferallee 1, 60438 Frankfurt am Main, Germany
| | - L. L. J. Quéléver
- Institute for Atmospheric and Earth System Research/INAR–Physics, Faculty of Science, University of Helsinki, 00560 Helsinki, Finland
| | - N. Sarnela
- Institute for Atmospheric and Earth System Research/INAR–Physics, Faculty of Science, University of Helsinki, 00560 Helsinki, Finland
| | - S. Schallhart
- Institute for Atmospheric and Earth System Research/INAR–Physics, Faculty of Science, University of Helsinki, 00560 Helsinki, Finland
| | | | - M. Sipilä
- Institute for Atmospheric and Earth System Research/INAR–Physics, Faculty of Science, University of Helsinki, 00560 Helsinki, Finland
| | - A. Tomé
- IDL Universidade da Beira Interior, Covilhã, Portugal
| | - J. Tröstl
- Laboratory of Atmospheric Chemistry, Paul Scherrer Institute, 5232 Villigen, Switzerland
| | - O. Väisänen
- University of Eastern Finland, Department of Applied Physics, P.O. Box 1627, 70211 Kuopio, Finland
| | - A. C. Wagner
- Goethe University Frankfurt, Institute for Atmospheric and Environmental Sciences, Altenhöferallee 1, 60438 Frankfurt am Main, Germany
| | - A. Ylisirniö
- University of Eastern Finland, Department of Applied Physics, P.O. Box 1627, 70211 Kuopio, Finland
| | - Q. Zha
- Institute for Atmospheric and Earth System Research/INAR–Physics, Faculty of Science, University of Helsinki, 00560 Helsinki, Finland
| | - U. Baltensperger
- Laboratory of Atmospheric Chemistry, Paul Scherrer Institute, 5232 Villigen, Switzerland
| | | | - J. Curtius
- Goethe University Frankfurt, Institute for Atmospheric and Environmental Sciences, Altenhöferallee 1, 60438 Frankfurt am Main, Germany
| | - R. C. Flagan
- California Institute of Technology, 210-41, Pasadena, CA 91125, USA
| | - A. Hansel
- Institute for Atmospheric and Earth System Research/INAR–Physics, Faculty of Science, University of Helsinki, 00560 Helsinki, Finland
- University of Innsbruck, Institute for Ion and Applied Physics, 6020 Innsbruck, Austria
- IONICON GesmbH, Innsbruck, Austria
| | - I. Riipinen
- Department of Environmental Science and Analytical Chemistry (ACES) and Bolin Centre for Climate Research, Stockholm University, 10691 Stockholm, Sweden
| | - J. N. Smith
- Department of Chemistry, University of California, Irvine, CA 92697, USA
| | - A. Virtanen
- University of Eastern Finland, Department of Applied Physics, P.O. Box 1627, 70211 Kuopio, Finland
| | - P. M. Winkler
- University of Vienna, Faculty of Physics, Boltzmanngasse 5, 1090 Wien, Austria
| | - N. M. Donahue
- Carnegie Mellon University Center for Atmospheric Particle Studies, 5000 Forbes Ave., Pittsburgh, PA 15213, USA
| | - V.-M. Kerminen
- Institute for Atmospheric and Earth System Research/INAR–Physics, Faculty of Science, University of Helsinki, 00560 Helsinki, Finland
| | - M. Kulmala
- Institute for Atmospheric and Earth System Research/INAR–Physics, Faculty of Science, University of Helsinki, 00560 Helsinki, Finland
- Joint International Research Laboratory of Atmospheric and Earth System Sciences, School of Atmospheric Sciences, Nanjing University, Nanjing, China
- Aerosol and Haze Laboratory, Beijing Advanced Innovation Center for Soft Matter Science and Engineering, Beijing University of Chemical Technology, Beijing, China
- Helsinki Institute of Physics, FI-00014 Helsinki, Finland
| | - M. Ehn
- Institute for Atmospheric and Earth System Research/INAR–Physics, Faculty of Science, University of Helsinki, 00560 Helsinki, Finland
| | - D. R. Worsnop
- Institute for Atmospheric and Earth System Research/INAR–Physics, Faculty of Science, University of Helsinki, 00560 Helsinki, Finland
- Aerodyne Research Inc., Billerica, MA 01821, USA
- University of Eastern Finland, Department of Applied Physics, P.O. Box 1627, 70211 Kuopio, Finland
| |
Collapse
|
27
|
Lecas L, Hartmann L, Caro L, Mohamed-Bouteben S, Raingeval C, Krimm I, Wagner R, Dugas V, Demesmay C. Miniaturized weak affinity chromatography for ligand identification of nanodiscs-embedded G-protein coupled receptors. Anal Chim Acta 2020; 1113:26-35. [DOI: 10.1016/j.aca.2020.03.062] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/21/2020] [Revised: 03/27/2020] [Accepted: 03/31/2020] [Indexed: 12/14/2022]
|
28
|
Guyot L, Hartmann L, Mohammed-Bouteben S, Caro L, Wagner R. Preparation of Recombinant Membrane Proteins from Pichia pastoris for Molecular Investigations. ACTA ACUST UNITED AC 2020; 100:e104. [PMID: 32289210 DOI: 10.1002/cpps.104] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Abstract
Pichia pastoris is a eukaryotic microorganism reputed for its ability to mass-produce recombinant proteins, including integral membrane proteins, for various applications. This article details a series of protocols that progress towards the production of integral membrane proteins, their extraction and purification in the presence of detergents, and their eventual reconstitution in lipid nanoparticles. These basic procedures can be further optimized to provide integral membrane protein samples that are compatible with a number of structural and/or functional investigations at the molecular level. Each protocol provides general guidelines, technical hints, and specific recommendations, and is illustrated with case studies corresponding to several representative mammalian proteins. © 2020 by John Wiley & Sons, Inc. Basic Protocol 1: Production of membrane proteins in a P. pastoris recombinant clone using methanol induction Basic Protocol 2: Preparation of whole-membrane fractions Alternate Protocol 1: Preparation of yeast protoplasts Basic Protocol 3: Extraction of membrane proteins from whole-membrane fractions Basic Protocol 4: Purification of membrane proteins Alternate Protocol 2: Purification of membrane proteins from yeast protoplasts Alternate Protocol 3: Simultaneous protoplast preparation and membrane solubilization for purification of membrane proteins Basic Protocol 5: Reconstitution of detergent-purified membrane proteins in lipid nanoparticles.
Collapse
Affiliation(s)
- Lucile Guyot
- IMPReSs Facility, Biotechnology and Cell Signaling UMR 7242, CNRS-University of Strasbourg, Illkirch, Cedex, France.,NovAliX, Illkirch, France
| | - Lucie Hartmann
- IMPReSs Facility, Biotechnology and Cell Signaling UMR 7242, CNRS-University of Strasbourg, Illkirch, Cedex, France
| | - Sarah Mohammed-Bouteben
- IMPReSs Facility, Biotechnology and Cell Signaling UMR 7242, CNRS-University of Strasbourg, Illkirch, Cedex, France
| | - Lydia Caro
- IMPReSs Facility, Biotechnology and Cell Signaling UMR 7242, CNRS-University of Strasbourg, Illkirch, Cedex, France
| | - Renaud Wagner
- IMPReSs Facility, Biotechnology and Cell Signaling UMR 7242, CNRS-University of Strasbourg, Illkirch, Cedex, France
| |
Collapse
|
29
|
Jaumann R, Schmitz N, Ho TM, Schröder SE, Otto KA, Stephan K, Elgner S, Krohn K, Preusker F, Scholten F, Biele J, Ulamec S, Krause C, Sugita S, Matz KD, Roatsch T, Parekh R, Mottola S, Grott M, Michel P, Trauthan F, Koncz A, Michaelis H, Lange C, Grundmann JT, Maibaum M, Sasaki K, Wolff F, Reill J, Moussi-Soffys A, Lorda L, Neumann W, Vincent JB, Wagner R, Bibring JP, Kameda S, Yano H, Watanabe S, Yoshikawa M, Tsuda Y, Okada T, Yoshimitsu T, Mimasu Y, Saiki T, Yabuta H, Rauer H, Honda R, Morota T, Yokota Y, Kouyama T. Images from the surface of asteroid Ryugu show rocks similar to carbonaceous chondrite meteorites. Science 2020; 365:817-820. [PMID: 31439797 DOI: 10.1126/science.aaw8627] [Citation(s) in RCA: 80] [Impact Index Per Article: 20.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/31/2019] [Accepted: 07/23/2019] [Indexed: 11/02/2022]
Abstract
The near-Earth asteroid (162173) Ryugu is a 900-m-diameter dark object expected to contain primordial material from the solar nebula. The Mobile Asteroid Surface Scout (MASCOT) landed on Ryugu's surface on 3 October 2018. We present images from the MASCOT camera (MASCam) taken during the descent and while on the surface. The surface is covered by decimeter- to meter-sized rocks, with no deposits of fine-grained material. Rocks appear either bright, with smooth faces and sharp edges, or dark, with a cauliflower-like, crumbly surface. Close-up images of a rock of the latter type reveal a dark matrix with small, bright, spectrally different inclusions, implying that it did not experience extensive aqueous alteration. The inclusions appear similar to those in carbonaceous chondrite meteorites.
Collapse
Affiliation(s)
- R Jaumann
- German Aerospace Center (DLR), Institute of Planetary Research, Berlin, Germany. .,Free University of Berlin, Institute of Geosciences, Berlin, Germany
| | - N Schmitz
- German Aerospace Center (DLR), Institute of Planetary Research, Berlin, Germany
| | - T-M Ho
- DLR, Institute of Space Systems, Bremen, Germany
| | - S E Schröder
- German Aerospace Center (DLR), Institute of Planetary Research, Berlin, Germany
| | - K A Otto
- German Aerospace Center (DLR), Institute of Planetary Research, Berlin, Germany
| | - K Stephan
- German Aerospace Center (DLR), Institute of Planetary Research, Berlin, Germany
| | - S Elgner
- German Aerospace Center (DLR), Institute of Planetary Research, Berlin, Germany
| | - K Krohn
- German Aerospace Center (DLR), Institute of Planetary Research, Berlin, Germany
| | - F Preusker
- German Aerospace Center (DLR), Institute of Planetary Research, Berlin, Germany
| | - F Scholten
- German Aerospace Center (DLR), Institute of Planetary Research, Berlin, Germany
| | - J Biele
- DLR, Microgravity User Support Center, Linder Höhe, Cologne, Germany
| | - S Ulamec
- DLR, Microgravity User Support Center, Linder Höhe, Cologne, Germany
| | - C Krause
- DLR, Microgravity User Support Center, Linder Höhe, Cologne, Germany
| | - S Sugita
- Department of Earth and Planetary Science, School of Science, University of Tokyo, Tokyo 113-0033, Japan
| | - K-D Matz
- German Aerospace Center (DLR), Institute of Planetary Research, Berlin, Germany
| | - T Roatsch
- German Aerospace Center (DLR), Institute of Planetary Research, Berlin, Germany
| | - R Parekh
- German Aerospace Center (DLR), Institute of Planetary Research, Berlin, Germany.,Free University of Berlin, Institute of Geosciences, Berlin, Germany
| | - S Mottola
- German Aerospace Center (DLR), Institute of Planetary Research, Berlin, Germany
| | - M Grott
- German Aerospace Center (DLR), Institute of Planetary Research, Berlin, Germany
| | - P Michel
- Université Côte d'Azur, Observatoire de la Côte d'Azur, Centre National de la Recherche Scientifique, Laboratoire Lagrange, Nice, France
| | - F Trauthan
- German Aerospace Center (DLR), Institute of Planetary Research, Berlin, Germany
| | - A Koncz
- German Aerospace Center (DLR), Institute of Planetary Research, Berlin, Germany
| | - H Michaelis
- German Aerospace Center (DLR), Institute of Planetary Research, Berlin, Germany
| | - C Lange
- DLR, Institute of Space Systems, Bremen, Germany
| | | | - M Maibaum
- DLR, Microgravity User Support Center, Linder Höhe, Cologne, Germany
| | - K Sasaki
- DLR, Institute of Space Systems, Bremen, Germany
| | - F Wolff
- DLR, Institute of System Dynamics and Control, Oberpfaffenhofen, Germany
| | - J Reill
- DLR, Institute of Robotics and Mechatronics, Oberpfaffenhofen, Germany
| | - A Moussi-Soffys
- Centre National d'Études Spatiales, 18 Avenue E. Belin, Toulouse 31401, France
| | - L Lorda
- Centre National d'Études Spatiales, 18 Avenue E. Belin, Toulouse 31401, France
| | - W Neumann
- German Aerospace Center (DLR), Institute of Planetary Research, Berlin, Germany
| | - J-B Vincent
- German Aerospace Center (DLR), Institute of Planetary Research, Berlin, Germany
| | - R Wagner
- German Aerospace Center (DLR), Institute of Planetary Research, Berlin, Germany
| | - J-P Bibring
- L'Université de Paris Sud-Orsay, Institut d'Astrophysique Spatiale, Orsay, France
| | - S Kameda
- Department of Physics, Rikkyo University, 3-34-1 Nishi-Ikebukuro, Toshima, Tokyo 171-8501, Japan
| | - H Yano
- Institute of Space and Astronautical Science, Japan Aerospace Exploration Agency, Sagamihara, Japan
| | - S Watanabe
- Institute of Space and Astronautical Science, Japan Aerospace Exploration Agency, Sagamihara, Japan.,Department of Earth and Planetary Sciences, Nagoya University Furo-cho Chikusa-ku, Nagoya, Japan
| | - M Yoshikawa
- Institute of Space and Astronautical Science, Japan Aerospace Exploration Agency, Sagamihara, Japan
| | - Y Tsuda
- Institute of Space and Astronautical Science, Japan Aerospace Exploration Agency, Sagamihara, Japan
| | - T Okada
- Institute of Space and Astronautical Science, Japan Aerospace Exploration Agency, Sagamihara, Japan
| | - T Yoshimitsu
- Institute of Space and Astronautical Science, Japan Aerospace Exploration Agency, Sagamihara, Japan
| | - Y Mimasu
- Institute of Space and Astronautical Science, Japan Aerospace Exploration Agency, Sagamihara, Japan
| | - T Saiki
- Institute of Space and Astronautical Science, Japan Aerospace Exploration Agency, Sagamihara, Japan
| | - H Yabuta
- Department of Earth and Planetary Systems Science, Hiroshima University, Hiroshima, Japan
| | - H Rauer
- German Aerospace Center (DLR), Institute of Planetary Research, Berlin, Germany.,Free University of Berlin, Institute of Geosciences, Berlin, Germany
| | - R Honda
- Kochi University, Department of Information Science, Akebono, Kochi, Japan
| | - T Morota
- University of Tokyo, Department of Earth and Planetary Science, Hongo, Bunkyo, Tokyo, Japan
| | - Y Yokota
- Institute of Space and Astronautical Science, Japan Aerospace Exploration Agency, Sagamihara, Japan
| | - T Kouyama
- National Institute of Advanced Industrial Science and Technology, Aomi, Koto, Tokyo, Japan
| |
Collapse
|
30
|
Rogers PL, Staruszkiewicz W, Adams A, Atienza B, Berg RJ, Chin H, DesJardins C, Gilgan M, Hansen LB, Hummer W, Jahncke M, Jester E, Kennedy K, Krzynowek J, McLachlan D, Mowdy D, Newton RT, Personeau JC, Rorberg JA, Shum G, Thomas TS, Wagner R, Whitby C, Yuen G. Gas Chromatographic Method for Putrescine and Cadaverine in Canned Tuna and Mahimahi and Fluorometric Method for Histamine (Minor Modification of AOAC Official Method 977.13): Collaborative Study. J AOAC Int 2020. [DOI: 10.1093/jaoac/80.3.591] [Citation(s) in RCA: 30] [Impact Index Per Article: 7.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]
Abstract
Abstract
A collaborative study was conducted to test a modification to the AOAC fluorometric method for histamine (AOAC® Official Method 977.13) that substitutes 75% methanol as the extracting solvent. All other steps remain unchanged. The extracts prepared with 75% methanol were also used to collaboratively test a gas chromatographic (GC) method for determination of putrescine and cadaverine in seafood. In the GC method, the extracted diamines are converted to fluorinated derivatives, the reaction mixtures are passed through solid-phase extraction columns, and the derivatives are quantitated by electron capture GC after separation on an OV-225 column. Fourteen laboratories using the GC method for putrescine and cadaverine and 16 laboratories using the fluorometric method for histamine analyzed 14 canned tuna and raw mahimahi (including blind duplicates and a spike) containing 0.2-2.6 ppm putrescine, 0.6-9.1 ppm cadaverine, and 0.6-154 ppm histamine. At the 5 ppm level, recoveries ranged from 71 to 102% for putrescine and 77 to 112% for cadaverine; the respective repeatability relative standard deviations (RSDr) were 5.2 and 15%, and the respective reproducibility relative standard deviations (RSDR) were 8.8 and 18%. At the 50 ppm level, histamine recoveries ranged from 84 to 125%, RSDr was 3.6%, and RSDR was 9.4%. The GC method for determination of putrescine in canned tuna and cadaverine in canned tuna and mahimahi has been adopted first action by AOAC INTERNATIONAL, and the AOAC Official Method 977.13, Histamine in Seafood, Fluorometric Method, has been modified
Collapse
Affiliation(s)
- Patricia L Rogers
- U.S. Food and Drug Administration, Office of Seafood, 200 C St, SW, Washington, DC 20204
| | - Walter Staruszkiewicz
- U.S. Food and Drug Administration, Office of Seafood, 200 C St, SW, Washington, DC 20204
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
31
|
Carson MC, Breslyn W, Carmany J, Cross S, Farrington WH, Hahn A, Jaworski J, Lansdon P, Li M, Pearson D, Polli R, Shepherd E, Singh D, Sundlof S, Tieso T, Wagner R, Wentworth J, Wilson B. Simultaneous Determination of Multiple Tetracycline Residues in Milk by Metal Chelate Affinity Chromatography: Collaborative Study. J AOAC Int 2020. [DOI: 10.1093/jaoac/79.1.29] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
Abstract
To meet federal and state regulatory needs, a liquid chromatographic (LC) method with ultraviolet (UV) detection was developed for determination of 7 tetracyclines at 30 ng/mL in milk. Raw milk samples are defatted, acidified, and centrifuged to remove proteins, and tetracyclines are specifically absorbed from the milk by chelation with metal ions bound to small Chelating Sepharose Fast Flow columns. Tetracyclines are removed from these columns with EDTA-containing buffer, and extracts are further cleaned by ultrafiltration. Finally, extracts are concentrated and analyzed simultane ously by using on-line concentration. This method was validated in a collaborative study that involved 11 laboratories, including the authors’ laboratory. Each laboratory was asked to prepare and analyze known control and fortified milk samples, as well as 18 coded blind samples. Eight laboratories completed all analyses. Average interlaboratory recoveries for the known fortified samples ranged from 59% (methacycline at 15 ng/mL) to 78% (oxytetracy cline at 60 ng/mL). Average recovery for each of 7 residues at 30 ng/mL were between 60 and 110%, meeting single-residue guidelines for accuracy set by the U.S. Food and Drug Administration. Reproducibility relative standard deviation (RSDR) for the known fortified samples varied from 11 to 39%, with 6 of 7 residues at the 30 ng/mL level having RSDR values at or below 20%. Seven of 8 laboratories correctly identified blind control milk samples and all 28 residues present in blind samples. The metal chelate affinity—LC method for determination of multiple tetracycline residues in milk has been adopted first action by AOAC INTERNATIONAL.
Collapse
Affiliation(s)
- Mary C Carson
- U.S. Food and Drug Administration, Center for Veterinary Medicine, Division of Residue Chemistry, Belts viUe, MD 20705
| | - Wayne Breslyn
- U.S. Food and Drug Administration, Center for Veterinary Medicine, Division of Residue Chemistry, Belts viUe, MD 20705
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
32
|
Degener F, Opgen-Rhein B, Wagner R, Boehne M, Boecker D, Reineker K, Wiegand G, Racolta A, Müller G, Kiski D, Rentzsch A, Fischer M, Papakostas K, Ruf B, Hannes T, Khalil M, Kaestner M, Steinmetz M, ÖZcan S, Fischer G, Freudenthal N, Schweigmann U, Pickardt T, Huber C, Messroghli D, Schubert S. Prognostic Parameters for a Severe Disease Course in Pediatric Patients with Suspected Myocarditis: Data from the Prospective Multicenter Registry “MYKKE”. Thorac Cardiovasc Surg 2020. [DOI: 10.1055/s-0040-1705542] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
Affiliation(s)
| | | | | | | | | | | | - G. Wiegand
- University of Tuebingen, Tuebingen, Germany
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
33
|
Giel-Moloney M, Esteban M, Oakes BH, Vaine M, Asbach B, Wagner R, Mize GJ, Spies AG, McElrath J, Perreau M, Roger T, Ives A, Calandra T, Weiss D, Perdiguero B, Kibler KV, Jacobs B, Ding S, Tomaras GD, Montefiori DC, Ferrari G, Yates NL, Roederer M, Kao SF, Foulds KE, Mayer BT, Bennett C, Gottardo R, Parrington M, Tartaglia J, Phogat S, Pantaleo G, Kleanthous H, Pugachev KV. Recombinant HIV-1 vaccine candidates based on replication-defective flavivirus vector. Sci Rep 2019; 9:20005. [PMID: 31882800 PMCID: PMC6934588 DOI: 10.1038/s41598-019-56550-4] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/10/2019] [Accepted: 12/13/2019] [Indexed: 12/21/2022] Open
Abstract
Multiple approaches utilizing viral and DNA vectors have shown promise in the development of an effective vaccine against HIV. In this study, an alternative replication-defective flavivirus vector, RepliVax (RV), was evaluated for the delivery of HIV-1 immunogens. Recombinant RV-HIV viruses were engineered to stably express clade C virus Gag and Env (gp120TM) proteins and propagated in Vero helper cells. RV-based vectors enabled efficient expression and correct maturation of Gag and gp120TM proteins, were apathogenic in a sensitive suckling mouse neurovirulence test, and were similar in immunogenicity to recombinant poxvirus NYVAC-HIV vectors in homologous or heterologous prime-boost combinations in mice. In a pilot NHP study, immunogenicity of RV-HIV viruses used as a prime or boost for DNA or NYVAC candidates was compared to a DNA prime/NYVAC boost benchmark scheme when administered together with adjuvanted gp120 protein. Similar neutralizing antibody titers, binding IgG titers measured against a broad panel of Env and Gag antigens, and ADCC responses were observed in the groups throughout the course of the study, and T cell responses were elicited. The entire data demonstrate that RV vectors have the potential as novel HIV-1 vaccine components for use in combination with other promising candidates to develop new effective vaccination strategies.
Collapse
Affiliation(s)
| | - M Esteban
- Centro Nacional de Biotecnología (CNB-CSIC), Madrid, Spain
| | - B H Oakes
- Sanofi Pasteur, Cambridge, MA, 02139, USA
| | - M Vaine
- Sanofi Pasteur, Cambridge, MA, 02139, USA
| | - B Asbach
- University of Regensburg (UREG), Institute of Medical Microbiology and Hygiene, 93053, Regensburg, Germany
| | - R Wagner
- University of Regensburg (UREG), Institute of Medical Microbiology and Hygiene, 93053, Regensburg, Germany
- University Hospital Regensburg, Institute of Clinical Microbiology and Hygiene, 93053, Regensburg, Germany
| | - G J Mize
- Fred Hutchinson Cancer Research Center (FHCRC), Seattle, WA, 98109, USA
| | - A G Spies
- Fred Hutchinson Cancer Research Center (FHCRC), Seattle, WA, 98109, USA
| | - J McElrath
- Fred Hutchinson Cancer Research Center (FHCRC), Seattle, WA, 98109, USA
| | - M Perreau
- Service of Immunology and Allergy, Department of Medicine, Lausanne University Hospital, 1011, Lausanne, Switzerland
| | - T Roger
- Infectious Diseases Service, Department of Medicine, Lausanne University Hospital, 1011, Lausanne, Switzerland
| | - A Ives
- Infectious Diseases Service, Department of Medicine, Lausanne University Hospital, 1011, Lausanne, Switzerland
| | - T Calandra
- Infectious Diseases Service, Department of Medicine, Lausanne University Hospital, 1011, Lausanne, Switzerland
| | - D Weiss
- Bioqual Inc, Rockville, Maryland, 20850, USA
| | - B Perdiguero
- Centro Nacional de Biotecnología (CNB-CSIC), Madrid, Spain
| | - K V Kibler
- Arizona State University (ASU), Tucson, AZ, 85745, USA
| | - B Jacobs
- Arizona State University (ASU), Tucson, AZ, 85745, USA
| | - S Ding
- EuroVacc, Amsterdam, The Netherlands
| | - G D Tomaras
- Duke University Medical Center, Durham, North Carolina, 27710, USA
| | - D C Montefiori
- Duke University Medical Center, Durham, North Carolina, 27710, USA
| | - G Ferrari
- Duke University Medical Center, Durham, North Carolina, 27710, USA
| | - N L Yates
- Duke University Medical Center, Durham, North Carolina, 27710, USA
| | - M Roederer
- Vaccine Research Center, NIAID, NIH, Bethesda, MD, 20892, USA
| | - S F Kao
- Vaccine Research Center, NIAID, NIH, Bethesda, MD, 20892, USA
| | - K E Foulds
- Vaccine Research Center, NIAID, NIH, Bethesda, MD, 20892, USA
| | - B T Mayer
- Fred Hutchinson Cancer Research Center (FHCRC), Seattle, WA, 98109, USA
| | - C Bennett
- Fred Hutchinson Cancer Research Center (FHCRC), Seattle, WA, 98109, USA
| | - R Gottardo
- Fred Hutchinson Cancer Research Center (FHCRC), Seattle, WA, 98109, USA
| | | | | | - S Phogat
- Sanofi Pasteur, Cambridge, MA, 02139, USA
| | - G Pantaleo
- Service of Immunology and Allergy, Department of Medicine, Lausanne University Hospital, 1011, Lausanne, Switzerland
| | | | | |
Collapse
|
34
|
Hartmann L, Botzanowski T, Galibert M, Jullian M, Chabrol E, Zeder-Lutz G, Kugler V, Stojko J, Strub JM, Ferry G, Frankiewicz L, Puget K, Wagner R, Cianférani S, Boutin JA. VHH characterization. Comparison of recombinant with chemically synthesized anti-HER2 VHH. Protein Sci 2019; 28:1865-1879. [PMID: 31423659 DOI: 10.1002/pro.3712] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/27/2019] [Revised: 08/14/2019] [Accepted: 08/14/2019] [Indexed: 12/12/2022]
Abstract
In the continuous exploration of the VHH chemistry, biochemistry and therapeutic future use, we investigated two different production strategies of this small antibody-like protein, using an anti-HER2 VHH as a model. The total chemical synthesis of the 125 amino-acid peptide was performed with reasonable yield, even if optimization will be necessary to upgrade this kind of production. In parallel, we expressed the same sequence in two different hosts: Escherichia coli and Pichia pastoris. Both productions were successful and led to a fair amount of VHHs. The integrity and conformation of the VHH were characterized by complementary mass spectrometry approaches, while surface plasmon resonance experiments were used to assess the VHH recognition capacity and affinity toward its "antigen." Using this combination of orthogonal techniques, it was possible to show that the three VHHs-whether synthetic or recombinant ones-were properly and similarly folded and recognized the "antigen" HER2 with similar affinities, in the nanomolar range. This opens a route toward further exploration of modified VHH with unnatural amino acids and subsequently, VHH-drug conjugates.
Collapse
Affiliation(s)
- Lucie Hartmann
- Plateforme IMPReSs, Laboratoire de Biotechnologie et Signalisation Cellulaire, CNRS, Université de Strasbourg, Illkirch, France
| | - Thomas Botzanowski
- Laboratoire de Spectrométrie de Masse BioOrganique, Université de Strasbourg, CNRS, Strasbourg, France
| | | | | | - Eric Chabrol
- PEX de Biotechnologie, Chimie et Biologie, Institut de REchercehs Servier, Croissy-sur-Seine, France
| | - Gabrielle Zeder-Lutz
- Plateforme IMPReSs, Laboratoire de Biotechnologie et Signalisation Cellulaire, CNRS, Université de Strasbourg, Illkirch, France
| | - Valérie Kugler
- Plateforme IMPReSs, Laboratoire de Biotechnologie et Signalisation Cellulaire, CNRS, Université de Strasbourg, Illkirch, France
| | - Johann Stojko
- PEX de Biotechnologie, Chimie et Biologie, Institut de REchercehs Servier, Croissy-sur-Seine, France
| | - Jean-Marc Strub
- Laboratoire de Spectrométrie de Masse BioOrganique, Université de Strasbourg, CNRS, Strasbourg, France
| | - Gilles Ferry
- PEX de Biotechnologie, Chimie et Biologie, Institut de REchercehs Servier, Croissy-sur-Seine, France
| | | | | | - Renaud Wagner
- Plateforme IMPReSs, Laboratoire de Biotechnologie et Signalisation Cellulaire, CNRS, Université de Strasbourg, Illkirch, France
| | - Sarah Cianférani
- Laboratoire de Spectrométrie de Masse BioOrganique, Université de Strasbourg, CNRS, Strasbourg, France
| | - Jean A Boutin
- Institut de Recherches Internationales Servier, Suresnes, France
| |
Collapse
|
35
|
Wagner R, Muggenthaler H, Sauer S, Mall G, Hubig M. Pedestrian hit by a car impacted metal pole: reconstructing the head load. Int J Legal Med 2019; 134:1403-1408. [PMID: 31388796 DOI: 10.1007/s00414-019-02133-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/26/2019] [Accepted: 07/26/2019] [Indexed: 11/28/2022]
Abstract
Fatal head injuries are frequently seen in pedestrians hit by motorized vehicles. In our case, the pedestrian sustained a devastating head injury with skull splitting in the mediosagittal plane. A car collided with a traffic sign causing a bending of the pole. The metal pole hit a man standing close beside it; the man had a head injury severity that is more commonly due to falling objects than due to traffic accidents. Assuming a head mass of 5 kg, simplified calculations yield maximum contact forces of ca. 36 kN exceeding mean parietal fracture forces which are in the order of magnitude of 12.5 kN. The influences of the effective body mass and the horizontal distance between the pole and the pedestrian on maximum contact forces are investigated. High contact forces in our case can be mainly explained by the comparably high impact velocity and by a partial mass transfer of the total car mass to the pole.
Collapse
Affiliation(s)
- R Wagner
- Institute of Legal Medicine, Jena University Hospital - Friedrich Schiller University Jena, Germany, Am Klinikum 1, 07747, Jena, Germany.
| | - H Muggenthaler
- Institute of Legal Medicine, Jena University Hospital - Friedrich Schiller University Jena, Germany, Am Klinikum 1, 07747, Jena, Germany
| | - S Sauer
- Institute of Legal Medicine, Jena University Hospital - Friedrich Schiller University Jena, Germany, Am Klinikum 1, 07747, Jena, Germany
| | - G Mall
- Institute of Legal Medicine, Jena University Hospital - Friedrich Schiller University Jena, Germany, Am Klinikum 1, 07747, Jena, Germany
| | - M Hubig
- Institute of Legal Medicine, Jena University Hospital - Friedrich Schiller University Jena, Germany, Am Klinikum 1, 07747, Jena, Germany
| |
Collapse
|
36
|
Lovec P, Savir-Baruch B, Gupta G, Wagner R, Gabriel M, Harkenrider M, Solanki A. Positive Findings on 18F-fluciclovine PET/CT in Patients with Suspected Recurrent Prostate Cancer and PSA levels ≤ 0.5 and ≤ 0.3 ng/ml. Int J Radiat Oncol Biol Phys 2018. [DOI: 10.1016/j.ijrobp.2018.07.015] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
37
|
Galli G, Volpato V, Santos R, Gebert R, Quatrin P, Ourique A, Klein B, Wagner R, Tonin A, Baldissera M, Stefani L, Da Silva A. Efectos del aceite esencial de Eucalyptus globulus cargado en nanoemulsiones y en nanocápsulas en la reproducción de la garrapata bovina (Rhipicephalus microplus). ARCH ZOOTEC 2018. [DOI: 10.21071/az.v0i0.3879] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
Abstract
La infestación por garrapatas (Rhipicephalus microplus), genera importantes pérdidas en la producción bovina. El objetivo de este estudio fue investigar si el aceite esencial de Eucalyptus globulus en diferentes nanosistemas (nanoemulsiones y nanocápsulas) es capaz de potenciar el efecto negativo sobre la reproducción de la garrapata, interfiriendo en su oviposición y eclosión de los huevos. Las hembras engordadas de R. microplus se obtuvieron de vacas naturalmente infestadas. En condiciones experimentales, estas hembras fueron sumergidas en soluciones de ensayo a concentraciones de 1, 5 y 10%, conteniendo aceite esencial puro de eucalipto; Y soluciones de la misma en nanocápsulas y nanoemulsiones, a concentraciones de 0,5, 1 y 5%. Las pruebas con aceite esencial de eucalipto puro, a concentraciones de 5 y 10%, mostraron 85 y 97,8% de eficacia, respectivamente. Sin embargo, el aceite encapsulado no fue capaz de potenciar el efecto carrapaticida, presentando 61,2% y 50% de eficacia (al 5%), utilizando nanoemulsiones y nanocápsulas. Por lo tanto, nuestros resultados nos permitieron concluir que el aceite esencial de E. globulus, en su forma pura, interfería negativamente en la reproducción de R. microplus; Sin embargo, las formas nanoestructuradas tenían baja eficacia.
Collapse
|
38
|
Koh N, Casey B, Newton R, Wagner R. ISQUA18-2101Formative Evaluation to Enhance Physician Training and Engagement in Patient Safety. Int J Qual Health Care 2018. [DOI: 10.1093/intqhc/mzy167.93] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- N Koh
- Accreditation Council for Graduate Medical Education, Chicago, United States
| | - B Casey
- Accreditation Council for Graduate Medical Education, Chicago, United States
| | - R Newton
- Accreditation Council for Graduate Medical Education, Chicago, United States
| | - R Wagner
- Accreditation Council for Graduate Medical Education, Chicago, United States
| |
Collapse
|
39
|
Wagner R, Passiment M, Newton R, Weiss K. ISQUA18-2596A National Learning Collaborative to Prepare New Physicians to Engage in Patient Safety. Int J Qual Health Care 2018. [DOI: 10.1093/intqhc/mzy167.42] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
| | | | | | - K Weiss
- ACGME, Chicago, United States
| |
Collapse
|
40
|
Wagner R. The 5 Layers of BIAO of Chinese Medicine and Their Correspondences in the Scientific Understanding of Modern Acupuncture. J Acupunct Meridian Stud 2018. [DOI: 10.1016/j.jams.2018.08.189] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022] Open
|
41
|
Sailer C, Stefan N, Schmid V, Fritsche L, Vosseler A, Wagner R, Peter A, Fritsche A, Häring HU, Heni M. Der Zusammenhang von LDL-Cholesterin mit Insulinsensitivität und Insulinsekretion. DIABETOL STOFFWECHS 2018. [DOI: 10.1055/s-0038-1641814] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Affiliation(s)
- C Sailer
- Institut für Diabetesforschung und Metabolische Erkrankungen (IDM) des Helmholtz-Zentrums München an der Eberhard-Karls-Universität, Tübingen, Germany
- Deutsches Zentrum für Diabetesforschung (DZD), Neuherberg, Germany
| | - N Stefan
- Institut für Diabetesforschung und Metabolische Erkrankungen (IDM) des Helmholtz-Zentrums München an der Eberhard-Karls-Universität, Tübingen, Germany
- Deutsches Zentrum für Diabetesforschung (DZD), Neuherberg, Germany
- Universitätsklinikum Tübingen, Innere Medizin IV, Endokrinologie, Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
| | - V Schmid
- Institut für Diabetesforschung und Metabolische Erkrankungen (IDM) des Helmholtz-Zentrums München an der Eberhard-Karls-Universität, Tübingen, Germany
- Deutsches Zentrum für Diabetesforschung (DZD), Neuherberg, Germany
- Universitätsklinikum Tübingen, Innere Medizin IV, Endokrinologie, Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
| | - L Fritsche
- Institut für Diabetesforschung und Metabolische Erkrankungen (IDM) des Helmholtz-Zentrums München an der Eberhard-Karls-Universität, Tübingen, Germany
- Deutsches Zentrum für Diabetesforschung (DZD), Neuherberg, Germany
| | - A Vosseler
- Institut für Diabetesforschung und Metabolische Erkrankungen (IDM) des Helmholtz-Zentrums München an der Eberhard-Karls-Universität, Tübingen, Germany
- Deutsches Zentrum für Diabetesforschung (DZD), Neuherberg, Germany
- Universitätsklinikum Tübingen, Innere Medizin IV, Endokrinologie, Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
| | - R Wagner
- Institut für Diabetesforschung und Metabolische Erkrankungen (IDM) des Helmholtz-Zentrums München an der Eberhard-Karls-Universität, Tübingen, Germany
- Deutsches Zentrum für Diabetesforschung (DZD), Neuherberg, Germany
- Universitätsklinikum Tübingen, Innere Medizin IV, Endokrinologie, Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
| | - A Peter
- Institut für Diabetesforschung und Metabolische Erkrankungen (IDM) des Helmholtz-Zentrums München an der Eberhard-Karls-Universität, Tübingen, Germany
- Deutsches Zentrum für Diabetesforschung (DZD), Neuherberg, Germany
- Universitätsklinikum Tübingen, Innere Medizin IV, Endokrinologie, Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
| | - A Fritsche
- Institut für Diabetesforschung und Metabolische Erkrankungen (IDM) des Helmholtz-Zentrums München an der Eberhard-Karls-Universität, Tübingen, Germany
- Deutsches Zentrum für Diabetesforschung (DZD), Neuherberg, Germany
- Universitätsklinikum Tübingen, Innere Medizin IV, Endokrinologie, Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
| | - HU Häring
- Institut für Diabetesforschung und Metabolische Erkrankungen (IDM) des Helmholtz-Zentrums München an der Eberhard-Karls-Universität, Tübingen, Germany
- Deutsches Zentrum für Diabetesforschung (DZD), Neuherberg, Germany
- Universitätsklinikum Tübingen, Innere Medizin IV, Endokrinologie, Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
| | - M Heni
- Institut für Diabetesforschung und Metabolische Erkrankungen (IDM) des Helmholtz-Zentrums München an der Eberhard-Karls-Universität, Tübingen, Germany
- Deutsches Zentrum für Diabetesforschung (DZD), Neuherberg, Germany
- Universitätsklinikum Tübingen, Innere Medizin IV, Endokrinologie, Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
| |
Collapse
|
42
|
Schmid V, Sailer C, Wagner R, Vosseler A, Stefan N, Häring HU, Fritsche A, Heni M. Die Verfügbarkeit von Glukose und freien Fettsäuren beeinflusst die Substratoxidation im Nüchternzustand. DIABETOL STOFFWECHS 2018. [DOI: 10.1055/s-0038-1641799] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Affiliation(s)
- V Schmid
- Institut für Diabetesforschung und metabolische Erkrankungen des Helmholtz Zentrums München an der Universität Tübingen (IDM), Tübingen, Germany
- Deutsches Zentrum für Diabetesforschung (DZD), Tübingen, Germany
- Innere Medizin IV, Endokrinologie, Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Universitätsklinikum Tübingen, Tübingen, Germany
| | - C Sailer
- Institut für Diabetesforschung und metabolische Erkrankungen des Helmholtz Zentrums München an der Universität Tübingen (IDM), Tübingen, Germany
- Deutsches Zentrum für Diabetesforschung (DZD), Tübingen, Germany
- Innere Medizin IV, Endokrinologie, Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Universitätsklinikum Tübingen, Tübingen, Germany
| | - R Wagner
- Institut für Diabetesforschung und metabolische Erkrankungen des Helmholtz Zentrums München an der Universität Tübingen (IDM), Tübingen, Germany
- Deutsches Zentrum für Diabetesforschung (DZD), Tübingen, Germany
- Innere Medizin IV, Endokrinologie, Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Universitätsklinikum Tübingen, Tübingen, Germany
| | - A Vosseler
- Institut für Diabetesforschung und metabolische Erkrankungen des Helmholtz Zentrums München an der Universität Tübingen (IDM), Tübingen, Germany
- Deutsches Zentrum für Diabetesforschung (DZD), Tübingen, Germany
- Innere Medizin IV, Endokrinologie, Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Universitätsklinikum Tübingen, Tübingen, Germany
| | - N Stefan
- Institut für Diabetesforschung und metabolische Erkrankungen des Helmholtz Zentrums München an der Universität Tübingen (IDM), Tübingen, Germany
- Deutsches Zentrum für Diabetesforschung (DZD), Tübingen, Germany
- Innere Medizin IV, Endokrinologie, Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Universitätsklinikum Tübingen, Tübingen, Germany
| | - HU Häring
- Institut für Diabetesforschung und metabolische Erkrankungen des Helmholtz Zentrums München an der Universität Tübingen (IDM), Tübingen, Germany
- Deutsches Zentrum für Diabetesforschung (DZD), Tübingen, Germany
- Innere Medizin IV, Endokrinologie, Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Universitätsklinikum Tübingen, Tübingen, Germany
| | - A Fritsche
- Institut für Diabetesforschung und metabolische Erkrankungen des Helmholtz Zentrums München an der Universität Tübingen (IDM), Tübingen, Germany
- Deutsches Zentrum für Diabetesforschung (DZD), Tübingen, Germany
- Innere Medizin IV, Endokrinologie, Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Universitätsklinikum Tübingen, Tübingen, Germany
| | - M Heni
- Institut für Diabetesforschung und metabolische Erkrankungen des Helmholtz Zentrums München an der Universität Tübingen (IDM), Tübingen, Germany
- Deutsches Zentrum für Diabetesforschung (DZD), Tübingen, Germany
- Innere Medizin IV, Endokrinologie, Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Universitätsklinikum Tübingen, Tübingen, Germany
| |
Collapse
|
43
|
Heni M, Wagner R, Willmann C, Jaghutriz BA, Vosseler A, Kübler C, Peter A, Häring HU, Preissl H, Kullmann S, Fritsche A. Insulinwirkung im Gehirn stimuliert die Insulinsekretion – Ergebnisse aus hyperglykämischen Clamps. DIABETOL STOFFWECHS 2018. [DOI: 10.1055/s-0038-1641796] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Affiliation(s)
- M Heni
- Universitätsklinikum Tübingen, Innere Medizin IV (Diabetologie, Nephrologie, Angiologie, Klinische Chemie), Tübingen, Germany
- Institut für Diabetesforschung und Metabolische Erkrankungen des Helmholtz Zentrum München an der Eberhard-Karls-Universität Tübingen, Tübingen, Germany
- Deutsches Zentrum für Diabetesforschung (DZD), München-Neuherberg, Germany
| | - R Wagner
- Universitätsklinikum Tübingen, Innere Medizin IV (Diabetologie, Nephrologie, Angiologie, Klinische Chemie), Tübingen, Germany
- Institut für Diabetesforschung und Metabolische Erkrankungen des Helmholtz Zentrum München an der Eberhard-Karls-Universität Tübingen, Tübingen, Germany
- Deutsches Zentrum für Diabetesforschung (DZD), München-Neuherberg, Germany
| | - C Willmann
- Universitätsklinikum Tübingen, Innere Medizin IV (Diabetologie, Nephrologie, Angiologie, Klinische Chemie), Tübingen, Germany
- Institut für Diabetesforschung und Metabolische Erkrankungen des Helmholtz Zentrum München an der Eberhard-Karls-Universität Tübingen, Tübingen, Germany
- Deutsches Zentrum für Diabetesforschung (DZD), München-Neuherberg, Germany
| | - BA Jaghutriz
- Universitätsklinikum Tübingen, Innere Medizin IV (Diabetologie, Nephrologie, Angiologie, Klinische Chemie), Tübingen, Germany
- Institut für Diabetesforschung und Metabolische Erkrankungen des Helmholtz Zentrum München an der Eberhard-Karls-Universität Tübingen, Tübingen, Germany
- Deutsches Zentrum für Diabetesforschung (DZD), München-Neuherberg, Germany
| | - A Vosseler
- Universitätsklinikum Tübingen, Innere Medizin IV (Diabetologie, Nephrologie, Angiologie, Klinische Chemie), Tübingen, Germany
- Institut für Diabetesforschung und Metabolische Erkrankungen des Helmholtz Zentrum München an der Eberhard-Karls-Universität Tübingen, Tübingen, Germany
- Deutsches Zentrum für Diabetesforschung (DZD), München-Neuherberg, Germany
| | - C Kübler
- Universitätsklinikum Tübingen, Innere Medizin IV (Diabetologie, Nephrologie, Angiologie, Klinische Chemie), Tübingen, Germany
| | - A Peter
- Universitätsklinikum Tübingen, Innere Medizin IV (Diabetologie, Nephrologie, Angiologie, Klinische Chemie), Tübingen, Germany
- Institut für Diabetesforschung und Metabolische Erkrankungen des Helmholtz Zentrum München an der Eberhard-Karls-Universität Tübingen, Tübingen, Germany
- Deutsches Zentrum für Diabetesforschung (DZD), München-Neuherberg, Germany
| | - HU Häring
- Universitätsklinikum Tübingen, Innere Medizin IV (Diabetologie, Nephrologie, Angiologie, Klinische Chemie), Tübingen, Germany
- Institut für Diabetesforschung und Metabolische Erkrankungen des Helmholtz Zentrum München an der Eberhard-Karls-Universität Tübingen, Tübingen, Germany
- Deutsches Zentrum für Diabetesforschung (DZD), München-Neuherberg, Germany
| | - H Preissl
- Universitätsklinikum Tübingen, Innere Medizin IV (Diabetologie, Nephrologie, Angiologie, Klinische Chemie), Tübingen, Germany
- Institut für Diabetesforschung und Metabolische Erkrankungen des Helmholtz Zentrum München an der Eberhard-Karls-Universität Tübingen, Tübingen, Germany
- Deutsches Zentrum für Diabetesforschung (DZD), München-Neuherberg, Germany
| | - S Kullmann
- Universitätsklinikum Tübingen, Innere Medizin IV (Diabetologie, Nephrologie, Angiologie, Klinische Chemie), Tübingen, Germany
- Institut für Diabetesforschung und Metabolische Erkrankungen des Helmholtz Zentrum München an der Eberhard-Karls-Universität Tübingen, Tübingen, Germany
- Deutsches Zentrum für Diabetesforschung (DZD), München-Neuherberg, Germany
| | - A Fritsche
- Universitätsklinikum Tübingen, Innere Medizin IV (Diabetologie, Nephrologie, Angiologie, Klinische Chemie), Tübingen, Germany
- Institut für Diabetesforschung und Metabolische Erkrankungen des Helmholtz Zentrum München an der Eberhard-Karls-Universität Tübingen, Tübingen, Germany
- Deutsches Zentrum für Diabetesforschung (DZD), München-Neuherberg, Germany
| |
Collapse
|
44
|
Siegel-Axel D, Jaghutriz BA, Peter A, Machann J, Kovarova M, Ullrich S, Gerst F, Nadalin S, Sipos B, Königsrainer A, Schick F, Stefan N, Fend F, Haen S, Häring HU, Wagner R, Schleicher E. Human fat depots show distinct quantitative, qualitative and functional inter-individual differences. DIABETOL STOFFWECHS 2018. [DOI: 10.1055/s-0038-1641835] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Affiliation(s)
- D Siegel-Axel
- Universitätsklinikum Tübingen (UKT), Medizinische Klinik IV, Abt. Endokrinologie, Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
- Institut für Diabetesforschung und Metabolische Erkrankungen des Helmholtz-Zentrums München an der Eberhard-Karls-Universität Tübingen, Neuherberg, Germany
- Deutsches Zentrum für Diabetesforschung (DZD), Tübingen, Germany
| | - BA Jaghutriz
- Universitätsklinikum Tübingen (UKT), Medizinische Klinik IV, Abt. Endokrinologie, Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
- Institut für Diabetesforschung und Metabolische Erkrankungen des Helmholtz-Zentrums München an der Eberhard-Karls-Universität Tübingen, Neuherberg, Germany
- Deutsches Zentrum für Diabetesforschung (DZD), Tübingen, Germany
| | - A Peter
- Universitätsklinikum Tübingen (UKT), Medizinische Klinik IV, Abt. Endokrinologie, Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
- Institut für Diabetesforschung und Metabolische Erkrankungen des Helmholtz-Zentrums München an der Eberhard-Karls-Universität Tübingen, Neuherberg, Germany
- Deutsches Zentrum für Diabetesforschung (DZD), Tübingen, Germany
| | - J Machann
- Sektion für Experimentelle Radiologie, Abteilung für Diagnostische und Interventionelle Radiologie, Radiologische Klinik, Tübingen, Germany
- Institut für Diabetes-Forschung und Metabolische Erkrankungen (IDM) – Metabolic Imaging des Helmholtz-Zentrums München an der Universität Tübingen, Neuherberg, Germany
| | - M Kovarova
- Universitätsklinikum Tübingen (UKT), Medizinische Klinik IV, Abt. Endokrinologie, Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
| | - S Ullrich
- Universitätsklinikum Tübingen (UKT), Medizinische Klinik IV, Abt. Endokrinologie, Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
- Institut für Diabetesforschung und Metabolische Erkrankungen des Helmholtz-Zentrums München an der Eberhard-Karls-Universität Tübingen, Neuherberg, Germany
- Deutsches Zentrum für Diabetesforschung (DZD), Tübingen, Germany
| | - F Gerst
- Universitätsklinikum Tübingen (UKT), Medizinische Klinik IV, Abt. Endokrinologie, Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
- Institut für Diabetesforschung und Metabolische Erkrankungen des Helmholtz-Zentrums München an der Eberhard-Karls-Universität Tübingen, Neuherberg, Germany
- Deutsches Zentrum für Diabetesforschung (DZD), Tübingen, Germany
| | - S Nadalin
- Klinik für Allgemeine, Viszeral- und Transplantationschirurgie, Universitätsklinikum (UKT), Tübingen, Germany
| | - B Sipos
- Klinik für Allgemeine, Viszeral- und Transplantationschirurgie, Universitätsklinikum (UKT), Tübingen, Germany
| | - A Königsrainer
- Klinik für Allgemeine, Viszeral- und Transplantationschirurgie, Universitätsklinikum (UKT), Tübingen, Germany
| | - F Schick
- Sektion für Experimentelle Radiologie, Abteilung für Diagnostische und Interventionelle Radiologie, Radiologische Klinik, Tübingen, Germany
| | - N Stefan
- Universitätsklinikum Tübingen (UKT), Medizinische Klinik IV, Abt. Endokrinologie, Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
- Institut für Diabetesforschung und Metabolische Erkrankungen des Helmholtz-Zentrums München an der Eberhard-Karls-Universität Tübingen, Neuherberg, Germany
- Deutsches Zentrum für Diabetesforschung (DZD), Tübingen, Germany
| | - F Fend
- Institut für Pathologie und Neuropathologie, Abt. für Allgemeine und Molekulare Pathologie und Pathologische Anatomie, Tübingen, Germany
| | - S Haen
- Institut für Pathologie und Neuropathologie, Abt. für Allgemeine und Molekulare Pathologie und Pathologische Anatomie, Tübingen, Germany
| | - HU Häring
- Universitätsklinikum Tübingen (UKT), Medizinische Klinik IV, Abt. Endokrinologie, Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
- Institut für Diabetesforschung und Metabolische Erkrankungen des Helmholtz-Zentrums München an der Eberhard-Karls-Universität Tübingen, Neuherberg, Germany
- Deutsches Zentrum für Diabetesforschung (DZD), Tübingen, Germany
| | - R Wagner
- Universitätsklinikum Tübingen (UKT), Medizinische Klinik IV, Abt. Endokrinologie, Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
- Institut für Diabetesforschung und Metabolische Erkrankungen des Helmholtz-Zentrums München an der Eberhard-Karls-Universität Tübingen, Neuherberg, Germany
- Deutsches Zentrum für Diabetesforschung (DZD), Tübingen, Germany
| | - E Schleicher
- Universitätsklinikum Tübingen (UKT), Medizinische Klinik IV, Abt. Endokrinologie, Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
- Institut für Diabetesforschung und Metabolische Erkrankungen des Helmholtz-Zentrums München an der Eberhard-Karls-Universität Tübingen, Neuherberg, Germany
- Deutsches Zentrum für Diabetesforschung (DZD), Tübingen, Germany
| |
Collapse
|
45
|
Lutz SZ, Fritsche L, Peter A, Rettig I, Wagner R, Willmann C, Fehlert E, Fritsche A, Häring HU, Heni M. Geschlechtsspezifischer Zusammenhang von Testosteron mit Insulinsensitivität. DIABETOL STOFFWECHS 2018. [DOI: 10.1055/s-0038-1641810] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Affiliation(s)
- SZ Lutz
- Universitätsklinikum Tübingen (UKT), Medizinische Klinik IV, Tübingen, Germany
- Institut für Diabetesforschung und Metabolische Erkrankungen des Helmholtz Zentrum München an der Eberhard-Karls-Universität Tübingen, Tübingen, Germany
- Deutsches Zentrum für Diabetesforschung (DZD e.V.), Tübingen, Germany
| | - L Fritsche
- Institut für Diabetesforschung und Metabolische Erkrankungen des Helmholtz Zentrum München an der Eberhard-Karls-Universität Tübingen, Tübingen, Germany
- Deutsches Zentrum für Diabetesforschung (DZD e.V.), Tübingen, Germany
| | - A Peter
- Universitätsklinikum Tübingen (UKT), Medizinische Klinik IV, Tübingen, Germany
- Institut für Diabetesforschung und Metabolische Erkrankungen des Helmholtz Zentrum München an der Eberhard-Karls-Universität Tübingen, Tübingen, Germany
- Deutsches Zentrum für Diabetesforschung (DZD e.V.), Tübingen, Germany
| | - I Rettig
- Universitätsklinikum Tübingen (UKT), Medizinische Klinik IV, Tübingen, Germany
| | - R Wagner
- Universitätsklinikum Tübingen (UKT), Medizinische Klinik IV, Tübingen, Germany
- Institut für Diabetesforschung und Metabolische Erkrankungen des Helmholtz Zentrum München an der Eberhard-Karls-Universität Tübingen, Tübingen, Germany
- Deutsches Zentrum für Diabetesforschung (DZD e.V.), Tübingen, Germany
| | - C Willmann
- Universitätsklinikum Tübingen (UKT), Medizinische Klinik IV, Tübingen, Germany
- Institut für Diabetesforschung und Metabolische Erkrankungen des Helmholtz Zentrum München an der Eberhard-Karls-Universität Tübingen, Tübingen, Germany
- Deutsches Zentrum für Diabetesforschung (DZD e.V.), Tübingen, Germany
| | - E Fehlert
- Universitätsklinikum Tübingen (UKT), Medizinische Klinik IV, Tübingen, Germany
- Institut für Diabetesforschung und Metabolische Erkrankungen des Helmholtz Zentrum München an der Eberhard-Karls-Universität Tübingen, Tübingen, Germany
- Deutsches Zentrum für Diabetesforschung (DZD e.V.), Tübingen, Germany
| | - A Fritsche
- Universitätsklinikum Tübingen (UKT), Medizinische Klinik IV, Tübingen, Germany
- Institut für Diabetesforschung und Metabolische Erkrankungen des Helmholtz Zentrum München an der Eberhard-Karls-Universität Tübingen, Tübingen, Germany
- Deutsches Zentrum für Diabetesforschung (DZD e.V.), Tübingen, Germany
| | - HU Häring
- Universitätsklinikum Tübingen (UKT), Medizinische Klinik IV, Tübingen, Germany
- Institut für Diabetesforschung und Metabolische Erkrankungen des Helmholtz Zentrum München an der Eberhard-Karls-Universität Tübingen, Tübingen, Germany
- Deutsches Zentrum für Diabetesforschung (DZD e.V.), Tübingen, Germany
| | - M Heni
- Universitätsklinikum Tübingen (UKT), Medizinische Klinik IV, Tübingen, Germany
- Institut für Diabetesforschung und Metabolische Erkrankungen des Helmholtz Zentrum München an der Eberhard-Karls-Universität Tübingen, Tübingen, Germany
- Deutsches Zentrum für Diabetesforschung (DZD e.V.), Tübingen, Germany
| |
Collapse
|
46
|
Jaghutriz BA, Wagner R, Heni M, Gerst F, Siegel-Axel DI, Ullrich S, Lehmann R, Machann J, Stefan N, Häring HU, Fritsche A. Metabolomic characteristics of fatty pancreas. DIABETOL STOFFWECHS 2018. [DOI: 10.1055/s-0038-1641787] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Affiliation(s)
- BA Jaghutriz
- Institut für Diabetesforschung und Metabolische Erkrankungen des Helmholtz Zentrum München an der Eberhard-Karls-Universität Tübingen, Tübingen, Germany
- Deutsches Zentrum für Diabetesforschung (DZD e.V.), Tübingen, Germany
- Universitätsklinikum Tübingen, Innere Medizin IV – Endokrinologie und Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
| | - R Wagner
- Institut für Diabetesforschung und Metabolische Erkrankungen des Helmholtz Zentrum München an der Eberhard-Karls-Universität Tübingen, Tübingen, Germany
- Deutsches Zentrum für Diabetesforschung (DZD e.V.), Tübingen, Germany
- Universitätsklinikum Tübingen, Innere Medizin IV – Endokrinologie und Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
| | - M Heni
- Institut für Diabetesforschung und Metabolische Erkrankungen des Helmholtz Zentrum München an der Eberhard-Karls-Universität Tübingen, Tübingen, Germany
- Deutsches Zentrum für Diabetesforschung (DZD e.V.), Tübingen, Germany
- Universitätsklinikum Tübingen, Innere Medizin IV – Endokrinologie und Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
| | - F Gerst
- Institut für Diabetesforschung und Metabolische Erkrankungen des Helmholtz Zentrum München an der Eberhard-Karls-Universität Tübingen, Tübingen, Germany
- Deutsches Zentrum für Diabetesforschung (DZD e.V.), Tübingen, Germany
- Universitätsklinikum Tübingen, Innere Medizin IV – Endokrinologie und Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
| | - DI Siegel-Axel
- Institut für Diabetesforschung und Metabolische Erkrankungen des Helmholtz Zentrum München an der Eberhard-Karls-Universität Tübingen, Tübingen, Germany
- Deutsches Zentrum für Diabetesforschung (DZD e.V.), Tübingen, Germany
- Universitätsklinikum Tübingen, Innere Medizin IV – Endokrinologie und Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
| | - S Ullrich
- Institut für Diabetesforschung und Metabolische Erkrankungen des Helmholtz Zentrum München an der Eberhard-Karls-Universität Tübingen, Tübingen, Germany
- Deutsches Zentrum für Diabetesforschung (DZD e.V.), Tübingen, Germany
- Universitätsklinikum Tübingen, Innere Medizin IV – Endokrinologie und Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
| | - R Lehmann
- Institut für Diabetesforschung und Metabolische Erkrankungen des Helmholtz Zentrum München an der Eberhard-Karls-Universität Tübingen, Tübingen, Germany
- Deutsches Zentrum für Diabetesforschung (DZD e.V.), Tübingen, Germany
- Universitätsklinikum Tübingen, Innere Medizin IV – Endokrinologie und Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
| | - J Machann
- Institut für Diabetesforschung und Metabolische Erkrankungen des Helmholtz Zentrum München an der Eberhard-Karls-Universität Tübingen, Tübingen, Germany
- Deutsches Zentrum für Diabetesforschung (DZD e.V.), Tübingen, Germany
- Universitätsklinikum Tübingen, Innere Medizin IV – Endokrinologie und Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
| | - N Stefan
- Institut für Diabetesforschung und Metabolische Erkrankungen des Helmholtz Zentrum München an der Eberhard-Karls-Universität Tübingen, Tübingen, Germany
- Deutsches Zentrum für Diabetesforschung (DZD e.V.), Tübingen, Germany
- Universitätsklinikum Tübingen, Innere Medizin IV – Endokrinologie und Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
| | - HU Häring
- Institut für Diabetesforschung und Metabolische Erkrankungen des Helmholtz Zentrum München an der Eberhard-Karls-Universität Tübingen, Tübingen, Germany
- Deutsches Zentrum für Diabetesforschung (DZD e.V.), Tübingen, Germany
- Universitätsklinikum Tübingen, Innere Medizin IV – Endokrinologie und Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
| | - A Fritsche
- Institut für Diabetesforschung und Metabolische Erkrankungen des Helmholtz Zentrum München an der Eberhard-Karls-Universität Tübingen, Tübingen, Germany
- Deutsches Zentrum für Diabetesforschung (DZD e.V.), Tübingen, Germany
- Universitätsklinikum Tübingen, Innere Medizin IV – Endokrinologie und Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
| |
Collapse
|
47
|
Jaghutriz BA, Heni M, Lutz S, Staiger H, Peter A, Häring HU, Fritsche A, Wagner R. SNP x SNP Interaktionen bestätigen die Rolle des Diabetes-Risikogens TCF7L2 in der Vermittlung der Inkretinwirkung. DIABETOL STOFFWECHS 2018. [DOI: 10.1055/s-0038-1641804] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Affiliation(s)
- BA Jaghutriz
- Institut für Diabetesforschung und Metabolische Erkrankungen des Helmholtz Zentrum München an der Eberhard-Karls-Universität Tübingen, Tübingen, Germany
- Deutsches Zentrum für Diabetesforschung (DZD e.V.), Tübingen, Germany
- Universitätsklinikum Tübingen, Innere Medizin IV – Endokrinologie und Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
| | - M Heni
- Institut für Diabetesforschung und Metabolische Erkrankungen des Helmholtz Zentrum München an der Eberhard-Karls-Universität Tübingen, Tübingen, Germany
- Deutsches Zentrum für Diabetesforschung (DZD e.V.), Tübingen, Germany
- Universitätsklinikum Tübingen, Innere Medizin IV – Endokrinologie und Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
| | - S Lutz
- Institut für Diabetesforschung und Metabolische Erkrankungen des Helmholtz Zentrum München an der Eberhard-Karls-Universität Tübingen, Tübingen, Germany
- Deutsches Zentrum für Diabetesforschung (DZD e.V.), Tübingen, Germany
- Universitätsklinikum Tübingen, Innere Medizin IV – Endokrinologie und Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
| | - H Staiger
- Institut für Diabetesforschung und Metabolische Erkrankungen des Helmholtz Zentrum München an der Eberhard-Karls-Universität Tübingen, Tübingen, Germany
- Deutsches Zentrum für Diabetesforschung (DZD e.V.), Tübingen, Germany
- Universitätsklinikum Tübingen, Innere Medizin IV – Endokrinologie und Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
| | - A Peter
- Institut für Diabetesforschung und Metabolische Erkrankungen des Helmholtz Zentrum München an der Eberhard-Karls-Universität Tübingen, Tübingen, Germany
- Deutsches Zentrum für Diabetesforschung (DZD e.V.), Tübingen, Germany
- Universitätsklinikum Tübingen, Innere Medizin IV – Endokrinologie und Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
| | - HU Häring
- Institut für Diabetesforschung und Metabolische Erkrankungen des Helmholtz Zentrum München an der Eberhard-Karls-Universität Tübingen, Tübingen, Germany
- Deutsches Zentrum für Diabetesforschung (DZD e.V.), Tübingen, Germany
- Universitätsklinikum Tübingen, Innere Medizin IV – Endokrinologie und Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
| | - A Fritsche
- Institut für Diabetesforschung und Metabolische Erkrankungen des Helmholtz Zentrum München an der Eberhard-Karls-Universität Tübingen, Tübingen, Germany
- Deutsches Zentrum für Diabetesforschung (DZD e.V.), Tübingen, Germany
- Universitätsklinikum Tübingen, Innere Medizin IV – Endokrinologie und Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
| | - R Wagner
- Institut für Diabetesforschung und Metabolische Erkrankungen des Helmholtz Zentrum München an der Eberhard-Karls-Universität Tübingen, Tübingen, Germany
- Deutsches Zentrum für Diabetesforschung (DZD e.V.), Tübingen, Germany
- Universitätsklinikum Tübingen, Innere Medizin IV – Endokrinologie und Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
| |
Collapse
|
48
|
Fruet APB, Trombetta F, Stefanello FS, Speroni CS, Donadel JZ, De Souza ANM, Rosado Júnior A, Tonetto CJ, Wagner R, De Mello A, Nörnberg JL. Effects of feeding legume-grass pasture and different concentrate levels on fatty acid profile, volatile compounds, and off-flavor of the M. longissimus thoracis. Meat Sci 2018; 140:112-118. [PMID: 29549844 DOI: 10.1016/j.meatsci.2018.03.008] [Citation(s) in RCA: 36] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/08/2017] [Revised: 01/29/2018] [Accepted: 03/08/2018] [Indexed: 11/16/2022]
Abstract
Pasture-finished beef is becoming more popular among consumers due to concerns related to fatty acid content and sustainable practices. The effects of finishing crossbred steers on legume-grass pasture comprised of oats, ryegrass, and clover (PAST), legume-grass pasture plus whole corn grain (WCG) supplementation (SUPP), and only with WCG (GRAIN) on fatty acids profile, volatile compounds, sensory, and texture attributes were studied. Pasture diets (PAST and SUPP) led to lower n-6/n-3 ratio (P < 0.001), and highest deposition of C18:2 cis-9 trans-11 (P < 0.001) in the lean. Beef from steers fed GRAIN had the highest values of volatile compounds associated with lipid oxidation. Off-flavor intensity was significantly greater on beef from steers fed GRAIN when compared to PAST. Overall, muscles from steers finished on PAST and SUPP showed similar attributes but differ when compared to GRAIN. The presence of forage is essential to improve fatty acid profile, decrease volatile compounds associated with lipid oxidation, and minimize off-flavor.
Collapse
Affiliation(s)
- A P B Fruet
- Department of Science and Food Technology, Federal University of Santa Maria, Santa Maria, 1000 Roraima Av., Santa Maria, RS 97105900, Brazil; Department of Agriculture, Nutrition, and Veterinary Sciences, University of Nevada, Reno, 1664 N. Virginia St. mail stop 202, Reno, NV 89557, United States.
| | - F Trombetta
- Department of Science and Food Technology, Federal University of Santa Maria, Santa Maria, 1000 Roraima Av., Santa Maria, RS 97105900, Brazil
| | - F S Stefanello
- Department of Science and Food Technology, Federal University of Santa Maria, Santa Maria, 1000 Roraima Av., Santa Maria, RS 97105900, Brazil
| | - C S Speroni
- Department of Science and Food Technology, Federal University of Santa Maria, Santa Maria, 1000 Roraima Av., Santa Maria, RS 97105900, Brazil
| | - J Z Donadel
- Department of Science and Food Technology, Federal University of Santa Maria, Santa Maria, 1000 Roraima Av., Santa Maria, RS 97105900, Brazil
| | - A N M De Souza
- Farroupilha Federal Institute, São Vicente do Sul, s/n 20 de Setembro St., São Vicente do Sul, RS 97420000, Brazil
| | - A Rosado Júnior
- Farroupilha Federal Institute, São Vicente do Sul, s/n 20 de Setembro St., São Vicente do Sul, RS 97420000, Brazil
| | - C J Tonetto
- Farroupilha Federal Institute, São Vicente do Sul, s/n 20 de Setembro St., São Vicente do Sul, RS 97420000, Brazil
| | - R Wagner
- Department of Science and Food Technology, Federal University of Santa Maria, Santa Maria, 1000 Roraima Av., Santa Maria, RS 97105900, Brazil
| | - A De Mello
- Department of Agriculture, Nutrition, and Veterinary Sciences, University of Nevada, Reno, 1664 N. Virginia St. mail stop 202, Reno, NV 89557, United States
| | - J L Nörnberg
- Department of Science and Food Technology, Federal University of Santa Maria, Santa Maria, 1000 Roraima Av., Santa Maria, RS 97105900, Brazil
| |
Collapse
|
49
|
Szentes B, Schwarzkopf L, Lehbert N, Wittmann M, Wagner R, Nowak D, Faller H, Schuler M, Schultz K. Is EQ-5D suited to assess quality of life aspects in pulmonary rehabilitation in bronchial asthma. Pneumologie 2018. [DOI: 10.1055/s-0037-1619413] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Affiliation(s)
- B Szentes
- Deutsches Foschungszentrum für Gesundheit und Umwelt, Helmholtz Zentrum München
| | - L Schwarzkopf
- Deutsches Foschungszentrum für Gesundheit und Umwelt, Helmholtz Zentrum München
| | - N Lehbert
- Zentrum für Rehabilitation, Klinik Bad Reichenhall der DRV Bayern Süd
| | - M Wittmann
- Zentrum für Rehabilitation, Klinik Bad Reichenhall der DRV Bayern Süd
| | - R Wagner
- Zentrum für Rehabilitation, Klinik Bad Reichenhall der DRV Bayern Süd
| | - D Nowak
- Institut und Poliklinik für Arbeits-, Sozial- und Umweltmedizin, Klinikum der Universität München
| | - H Faller
- Abteilung für Medizinische Psychologie und Psychotherapie, Universität Würzburg
| | - M Schuler
- Abteilung für Medizinische Psychologie und Psychotherapie, Universität Würzburg
| | - K Schultz
- Zentrum für Rehabilitation, Klinik Bad Reichenhall der DRV Bayern Süd
| |
Collapse
|
50
|
Schultz K, Wittmann M, Wagner R, Schwarzkopf L, Nowak D, Faller H, Schuler M. Stimmt der Asthmakontrolltest (ACT) mit den überarbeiteten GINA-Kriterien der Asthmasymptomkontrolle (ASC) überein? Pneumologie 2018. [DOI: 10.1055/s-0037-1619163] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Affiliation(s)
- K Schultz
- Klinik Bad Reichenhall der DRV Bayern Süd
| | - M Wittmann
- Klinik Bad Reichenhall der DRV Bayern Süd
| | - R Wagner
- Klinik Bad Reichenhall der DRV Bayern Süd
| | - L Schwarzkopf
- Institut für Gesundheitsökonomie und Management im Gesundheitswesen, Neuehrberg
| | - D Nowak
- Comprehensive Pneumology Center, Institut und Poliklinik für Arbeits-, Sozial- Und Umweltmedizin; Klinikum der LMU München
| | - H Faller
- Abteilung für Medizinische Psychologie und Psychotherapie; Medizinische Soziologie und Rehabilitationswissenschaften, Universität Würzburg
| | - M Schuler
- Abteilung für Medizinische Psychologie und Psychotherapie; Medizinische Soziologie und Rehabilitationswissenschaften, Universität Würzburg
| |
Collapse
|